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Abstract 
This qualitative case study examined the rising cost of hospital pharmaceutical shortages and the 
impact on patient care. This study also explored the use of predictive analytics to reduce costs 
and improve patient care efficiency. Increased health-care spending is partially due to 
prescription medication prices. Management of hospital drug procurement affects patient health, 
quality care, and hospital budgets, while risk management needs to minimize possible 
medication shortages. For patients to get the drugs that they need, pharmacists need to have 
resources at their fingertips to obtain a deep insight into the knowledge of drugs through the 
supply chain. The research questions concentrated on the causes of rising costs, the role of 
supply and demand, and the possibility of predictive analytics as a tool for inefficiencies relating 
to rising costs of hospital pharmaceutical shortages. The unexpected factor in this study was the 
impact of the Coronavirus (COVID-19) pandemic. Not only did COVID-19 alter the data 
collection method, but the data itself. Hospital pharmaceuticals were and still are greatly affected 
by the pandemic. The findings from this study was applied to the professional practice of 
business. Additionally, the researcher discussed the implication of the biblical worldview and the 
implication of the strategic management field of study. The report finished with suggestions for 
practice, suggestions for further analysis, reflections, and conclusions. The researcher also 
recommended that the study be conducted again with a specific pharmaceutical shortage and no 
global pandemic. 
Key words: pharmaceutical shortages, manufacturer, strategic management, efficient patient 
care, COVID-19  
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Section 1: Foundation of the Study 
General supervision of the supply chain is frequently inefficient and wasteful (Hart & 
McMurtrey, 2018). The increasing amount of healthcare expenditure is partly due to the cost of 
pharmaceutical drugs. Management of hospital drug procurement impacts patient safety, quality 
care, and hospital budgets, while risk management needs to mitigate possible drug shortages. 
Additionally, pharmaceutical shortages can harm patient drug therapies, which result in 
medication errors and delay in medical procedures (Shaban et al., 2018).  
This study examined the rising cost of hospital pharmaceuticals shortages and how they 
impact patient care. The first section of this study began with a review of the business problem, 
its purpose, and the nature of which the study was conducted. After the nature of the study, the 
research questions were discussed, and the conceptual framework was established. The 
researcher defined terms, assumptions, limitations, and delimitations for the study. Observations 
of the potential reduction of gaps, Biblical integration, and the relationship to the writer’s field of 
study was discussed. The first section ended with a review of the academic and professional 
literature related to the business problem. This study addressed prescription shortages due to 
forecast errors and manufacturing problems.  
Background of the Problem 
In the healthcare delivery system, pharmaceutical inventory management is complex but 
vital for patient care and operations. According to Kagashe and Massawe (2012), inadequate and 
unsystematic monitoring of pharmaceuticals, and inaccurate stock records all lead to poor 
pharmaceutical inventory management. Moons et al. (2019) argued that the process of 
performance measurement in any supply chain is essential to address inpatient care inefficiencies 
and to control rising supply chain inventory costs. Moreover, the ability to use data to predict 
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pharmaceutical shortages and their effects will be crucial to decrease costs and improve patient 
care efficiency. Rachmania and Basri (2013) claimed to maintain drugs' availability; it is 
essential to know the levels of drugs in a pharmaceutical supply chain. Drug shortages may 
happen for an assortment of reasons, including manufacturing problems, raw material shortages, 
regulatory problems, natural disasters, and voluntary recalls. Healthcare facility and patient care 
operations are disrupted by poor inventory management (Vila-Parrish et al., 2012). Moreover, 
when pharmaceutical inventory management is subjected to poor practices, there can be 
substantial shortages and inefficiencies that affect healthcare supply delivery (Landis, 2002).  
Mustaffa and Potter (2009) emphasized the importance of efficient internal inventory 
management. For optimizing the medical supply system’s efficiency, pharmaceutical inventory 
management needs to be improved (Almarsdotti & Traulser, 2005; Kelle et al., 2012; Shah, 
2004). Castellanos (2019) reported that analysts predict that using data for precise supply-and-
demand forecasts could save hundreds of millions of dollars a year through better inventory 
management for drug makers and hospitals. Moreover, finding a useful data tool that can help 
specifically with pharmaceutical shortage planning can be valuable to the hospital supply chain's 
operations. From the background of the problem, it was established that a comprehensive study 
on the rising costs of hospital pharmaceutical shortages and the impact on patient care in New 
York. 
Problem Statement 
The general problem addressed was the rising cost of hospital pharmaceutical shortages 
and the impact on patient care. Hospitals continue to feel pressure from society to provide 
affordable, safe, and quality service to patients despite rising medical costs due to un-optimized 
and wasteful supply chain management (Dobrzykowski et al., 2014). A report by the American 
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Hospital Association (AHA), the American Society of Health-System Pharmacists (ASHP), and 
the Federation of American Hospitals (FAH) stated that the strain on hospital budgets, 
operations, and patient care continues to be impacted by rising costs of hospital pharmaceutical 
shortages (ASHP, 2019). Pharmaceutical supply chain shortages are caused by many issues such 
as forecasting errors, plant quality problems, manufacturer consolidation, and a lack of 
incentives to produce generic brands, increase in demand, and product recalls (Azghandi et al., 
2018; Mazer et al., 2014). This study addressed pharmaceutical shortages due to forecast errors 
and manufacturing problems. Manufacturing is the link between study and patient; there is no 
medical result without a product. 
Heiskanen et al. (2017) argued that manufacturing issues, long or complicated output, 
was the most common cause of drug shortages. It is more difficult to control the quality of the 
manufacturing chain as the manufacturing chain becomes more complicated and longer. It was 
assumed that a long and complicated manufacturing chain and the use of several subcontractors 
would not only jeopardize the availability of drugs but would also increase the risk of quality 
problems and increase the cost of manufacturing (Heiskanen et al., 2017). The specific problem 
addressed was the rising costs of hospital pharmaceutical shortages related to manufacturing 
issues and the impact on patient care in New York hospitals.  
Purpose Statement 
The purpose of this qualitative case study was to add to the body of knowledge by 
expanding on the understanding of factors driving the rising cost of hospital pharmaceutical 
shortages relating to manufacturing problems and the impact on patient care. The integration and 
coordination of the hospital pharmaceutical supply chain are essential to support patients' care 
(Sweeney, 2011a). Hospital supply chain management has many issues, including increased 
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supplies, manufacturing problems, logistics, and distribution issues. When the supply chain is 
managed effectively, it can positively affect the hospital's bottom line (de Vries & Huijsman, 
2011). Pharmaceutical supply chain management's critical objectives should improve the 
fulfillment of demand efficiently, drive extraordinary client value, build system resiliency, and 
promote financial success (Gibson et al., 2005). The more significant problem was explored by 
studying the rising cost of hospital pharmaceutical shortages, associated with manufacturing 
problems, the impact on patient care, and exploring the use of predictive analytics in New York 
area hospitals. 
Predictive analytics is a concept describing the use of past data to develop informed 
assumptions about future results. Many businesses have been using this sophisticated method to 
assess risk, detect fraud, and the demand for products or services. The study's role in predictive 
analytics was a method for using data to predict and adapt to changing demands based on 
historical events and prevailing trends (Brooks, 2018).  
Nature of the Study 
 Research methods in business are utilized by organizations to decide whether a particular 
business venture merits time and other resources. Likewise, research methods help organizations 
assess business success viability and select the right marketing approach for goods and services. 
Before conducting research, organizations usually define the problem and purpose that a research 
study seeks to explore. After the problem and purpose were established, the most suitable 
research method was selected. Three research methods are used to support the purpose statement: 
qualitative, quantitative, and mixed methods. This section discussed the chosen research method 
and design and the relation to the purpose statement. Additionally, it examined the research 
methods and design used in the study compared to the alternatives.  
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Discussion of Method 
Pathak et al. (2013) indicated that qualitative research centers on understanding an 
exploration inquiry as an idealistic or humanistic methodology. To comprehend the interactions, 
conduct, beliefs, and experiences, a researcher will use a qualitative method. The qualitative 
research strategy is becoming more popular across disciplines by its assimilation of research into 
intermediation studies (Sofaer, 1999). Most generally, qualitative research involves methodical 
gathering, requesting, interpretation, and description of written data produced from perception, 
talk/interview, or existing records. 
Qualitative research designs incorporate questioning, perception, and archival 
examination (Miles & Huberman, 1994). It will probably investigate the conduct, procedures of 
cooperation, and the implications, qualities, and encounters of deliberately sampled individual 
participants and groups in their ordinary setting. Consequently, the qualitative research method 
best suited the current study exploring the rising costs of hospital pharmaceutical shortage, the 
impact on patient care, and the use of predictive analytics in New York area hospitals. 
The quantitative research method was not chosen because the quantitative method relies 
on numerical analysis, science, and the cause and effect of relationships. Quantitative research 
usually includes examining a large group of individuals, using a controlled survey that includes 
mainly forced-choice, or closed-ended questions. Quantitative analysis is best used when the 
results need to be conveyed mathematically, allowing organizations to garner statistics upon 
which predictions and plans can be made. A study that aims to gain insight into the experience 
with a phenomenon could not be reached with the quantitative method (Creswell, 2014). 
The mixed methods research approach was not selected because it is a combination of 
quantitative and qualitative research methods. It includes philosophical presumptions, the 
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utilization of quantitative and qualitative methodologies, and the blending of both approaches 
within a single study to provide a better understanding than a single approach (Creswell & Plano 
Clark, 2007). Therefore, the mixed methods research method was unsuitable for exploring the 
current business problem. 
Discussion of Design 
Qualitative studies can be accomplished with one of the five qualitative designs; 
narrative, phenomenology, case studies, ethnography, and grounded theory. The focal point of 
the case study design is to investigate how a group of individuals perceive their experiences with 
a phenomenon (Creswell, 2016). Case study research has developed in notoriety as a powerful 
technique to explore and comprehend complicated issues in world settings. The source of case 
study design exists in the fields of politics, law, psychology, and medicine. Although there are 
roots of humanities and social science for the cutting-edge sociology contextual investigation 
(Yin, 2014) when a researcher selects a collective or multiple case study, they can address an 
issue either by multiple programs with one site, or multiple programs from multiple sites 
(Creswell & Poth, 2018).  
For an examination of rising costs of hospital pharmaceutical shortages and the impact on 
patient care, exploring the use of predictive analytics in New York area hospitals, a multiple case 
design will give any insight into the single phenomenon. The qualitative case study design was 
chosen, following a thorough review of the remaining four designs. Narrative research can be 
described as a research design that is grounded in different disciplines of social sciences and 
humanities. Even though narrative research is grounded in social science and humanities, it also 
has origin related to education, history, and anthropology. Different approaches exist for 
different fields of study. Narrative design is the lived experiences of an individual(s) through 
7 
 
their stories with an emphasis on what happened in the story and how. The narrative design has 
several forms and uses an assortment of analytical practices (Creswell & Poth, 2018). The 
narrative design was not the chosen research design because its focus is on the experiences of an 
individual or a phenomenon being studied in chronological order by posing story-based 
questions to the participants sampled from the study population (Creswell & Poth). Hence, the 
narrative design was not appropriate for this study. 
The qualitative grounded theory design reaches beyond the participants’ shared 
experiences. The grounded theory aims to generate or discover a theory for those who 
experienced the process (Creswell & Poth, 2018). Aldiabat and Le Navenec (2011) described it 
as an explanation of a theory that is unified. The data collected from participants are what ground 
the theoretical development. The origin of grounded theory is in social and behavioral sciences. 
The origin of the grounded theory lies in the social and behavioral sciences. To help predict how 
people are acting and how events are progressing, a theory is developed as an explanation. 
Grounded theory can be narrow or broad, and the process is broken into steps as it unfolds 
(Creswell, 2016). Grounded theory was not appropriate for the qualitative study because the 
study is not intended to create a new theory. 
An ethnographic investigation includes shared examples of conduct, language, and 
convictions of a whole culture. The procedure of an ethnographic examination begins with inside 
and out, common submerged perception of the members (Creswell & Poth, 2018). Ethnographic 
research started in similar social humanities. Ethnography is also used in sociologies and social 
sciences, and is widely recognized in wellness research (Reeves et al., 2008). Some examples of 
ethnography logical methodologies include woman's rights, Marxism, primary hypothesis, and 
postmodernism to give some examples. Because of the absence of universality, pluralistic 
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methodologies are developed (Creswell & Poth, 2018). Ethnography would not be an appropriate 
structure, since it is limited to depicting the functions of a cultured group by investigating 
practices, convictions, and language. 
A research study that focuses on an individual(s) that experience a specific phenomenon 
and what the individuals have in common is the qualitative design of phenomenology. 
Phenomenology is the investigation of structures of cognizance as experienced from the primary 
individual perspective. The focal structure of an experience is its purposefulness, and it's being 
coordinated toward something, as it is an experience of or about some object. An experience is 
coordinated toward an object by the righteousness of its substance or significance (which speaks 
to the object) together with proper empowering conditions (Creswell & Poth, 2018).  
Phenomenology as an order is unmistakable from however it identifies with other key 
disciplines in reasoning, for example, logic, ontology, epistemology, and morals. 
Phenomenological studies structure cognizant experiences from the individual perspective, 
alongside appropriate states of understanding. The focal structure of an experience is its 
deliberateness, how it is coordinated through its substance or importance toward a specific object 
in the world (Moran, 2000). Hence, the phenomenological research design was not chosen 
because human experiences were the focus and their thoughts over experiences with the 
phenomenon (Creswell & Poth, 2018). 
As stated above, the best research method and design for exploring the rising costs of 
hospital pharmaceutical shortages, the impact on patient care, and the use of predictive analytics 
in New York area hospitals, was a qualitative case study. Harrison et al. (2017) stated the case 
study design is appropriate because it connects with the study's purposes and gives the researcher 
the tools to obtaining relevant information for solutions for the research problem. 
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Summary of the Nature of the Study 
The qualitative method and case study design was chosen to study the rising cost of 
hospital pharmaceutical shortages, the impact on patient care and the use of predictive analytics 
in New York area hospitals. This method was chosen by the researcher because it was the most 
appropriate way to address the business problem and explore the cases and how the problem 
could be resolved. The researcher used semi-structured interviews to allow for further detail to 
be collected on the subject of the rising costs of hospital pharmaceuticals and the impact on 
patient care. The qualitative study also explored the use of predictive analytics as a possible 
business problem solution.  
Research Questions 
In the healthcare field, presenting innovation and management approaches is not as fast 
as other businesses, mainly since healthcare organizations generally have moderate cultures 
shaped by employees’ special calling, which is sparing the human life (Moons et al., 2019). 
Scott-Cawiezell et al. (2009) stated that hospital pharmacies anticipate diminishing costs for 
operations while guaranteeing patient security. For pharmaceutical and healthcare organizations 
to optimize medication usage, there should be a system in place to be successful. In any case, the 
logistics of hospital pharmacies are identified with a few issues that affect the expense and nature 
of the prescription services adversely. Effective patient care that has been influenced by 
inventory management consists of strategic decisions of predictive analytics and emerging 
technology. Cohesive hospital management of supply chain strategy enables organizations to 
increase efficiency.  
Moreover, effective execution of a cohesive method results in decreased costs and, in 
addition to the end of excess exercises, every one of these advantages converts into cash 
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investment funds inside the hospitals (Hart & McMurtrey, 2018). Designing effective procedures 
for supply chain management is vital to the success of overall hospital operations. Inventory 
misplacement, shortages in pharmacy supplies and less than optimal preemptive measures, all 
play into the truth that hospitals are focal points for inefficiencies without an appropriate system 
for supply chain management (Kim & Kwon, 2015). This qualitative case study addresses the 
problem of the rising costs of hospital pharmaceutical shortages related to manufacturing 
problems in New York hospitals, with the following research questions: 
RQ1. How are hospitals challenged by the rising costs of hospital pharmaceutical 
shortages due to manufacturing problems?  
RQ2. What role does supply and demand management play in hospital pharmaceutical 
shortages?  
RQ3. How would predictive analytics improve patient care inefficiencies relating to 
rising costs of hospital pharmaceutical shortages?  
Conceptual Framework 
 An organizing tool particularly useful in experimental research is the conceptual 
framework (Shields & Rangarajan, 2013). MacFarlane and O'Reilly-de Brún (2012) explained 
how a conceptual framework plans out the required activities during a study, given the 
researcher's prior comprehension of others' perspectives or learning on the researched subject. 
The conceptual framework for this qualitative case study added to the literature on the rising 
costs of hospital pharmaceutical shortages and the impact on patient care in New York hospitals.  
 The importance of hospital pharmaceutical efficiency. According to Manuel and Rossetti 
et al. (2008), pharmaceutical inventory management has a vital role in a hospital supply chain. 
Studies have shown the importance of healthcare industry operations and decision support tools 
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that improve wellbeing, general wellbeing, persistent security, and essential critical leadership in 
the pharmaceutical supply chain. Medication deficiencies and ill-advised utilization of 
pharmaceuticals can prompt financial losses as well as significantly affect patients. The Group 
Purchasing Organization (GPO) /healthcare technology provider, Vizient, estimated that drug 
shortages would represent an annual additional $360 million to hospital costs, including other 
labor costs of pharmacy and clerical employees (Pharmaceutical Commerce, 2019). A high level 
of service for effective inventory policies and medical supplies is essential for all healthcare 
industries. 
 Many health systems and emergency clinics experience challenges in accomplishing 
effective inventory management as they have disregarded how drugs are overseen, provided, and 
used to spare lives and improve wellbeing (Uthayakumar & Priyan, 2013). Almarsdóttir and 
Traulsen (2005) noted the various reasons why pharmaceuticals deserve extraordinary thought in 
inventory control; in the current financial crisis, increasing consideration is being centered on the 
increasing expenses of health care and explicitly, pharmaceuticals. Uthayakumar and Priyan 
(2013) stated that pharmaceutical products could be costly to purchase and dispense. Yet, the ill-
advised use of prescriptions, deficiencies in basic medicines, and expenditure on superfluous or 
low-quality meds additionally have a huge cost of wasted assets and preventable disease and 
death. 
 Rising costs of hospital pharmaceutical shortages. One of the intentions of the Affordable 
Care Act is to regulate the cost of pharmaceuticals. Depending upon its unique drug formulary 
and residing state, medications will be different. In the marketplace of all health plans, 
prescription drug coverage is mandatory (Edmunds, 2016). Challenges with rising hospital 
pharmaceutical shortage costs could fundamentally draw down the medicinal business and 
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become unfavorable to the lives of individuals around the world (Sherwin, 2013). There are more 
significant challenges in hospital pharmaceutical inventory management because of hospital 
pharmaceutical shortages relating to manufacturing problems.  
According to Bogaert et al. (2015), shortages due to manufacturing problems usually last 
longer than those due to problems with the supply chain. While when a manufacturing problem 
occurs, it is sometimes necessary to remove from commission a whole production chain. Current 
strategy initiatives have had limited success in dealing with drug shortages. Since 2004, 
pharmaceutical drug shortages have become more frequent and progressively severe. 
Additionally, shortages have a more significant impact on the care of patients and have become 
longer in duration. The rise in healthcare costs will motivate hospitals to strategically structure 
the supply chain that could enable them to control costs, forecast demand shortage, and better 
serve their patients (Sweeney et al., 2018). According to Gu et al. (2011), holding conversations 
and probing for practical solutions to drug shortages is critical given the drugs in shortage are 
essential for treating basic wellbeing conditions and deficiencies. 
Pharmaceutical Supply and Demand Management  
 The components of a hospital pharmaceutical inventory are a large operating expense. 
Jurado et al. (2016) claimed one of the main tasks of a pharmacy is stock management. “It is a 
complex problem due to the uncertainty in the drug demand and the variety of constraints to be 
considered” (Jurado et al., 2016, p. 254). Literature reveals that pharmaceutical inventory can be 
estimated around 20% of revenues for the healthcare industry (Kelle et al., 2012). Therefore, it is 
essential to apply measures that may control the pharmaceutical inventory and, in turn, have a 
positive cost effect on the hospital’s overall efficiency. The intricacy of the issue lies in the 
random nature of the medication demand and the numerous requirements that must be 
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considered in each decision. The clinical requirement for medications must be satisfied with 
fewer resources while limiting the utilization of financial assets (Liu et al., 2017). 
Business Strategy and Predictive Analytics  
 The implementation of a business strategy and process improvement would be beneficial 
for the management of hospital pharmaceutical inventory. The Food and Drug Administration 
(FDA) acknowledge that the lack of robustness, agility, innovation and flexibility in the 
pharmaceutical industry poses a potential threat to public health as defects in manufacturing 
facilities leading to poor product quality could lead to drug shortages (Lee et al., 2015). To 
improve service levels and lessen cost, some healthcare facilities have evaluated alternative 
supply chain methods. Data from supply chains of medicines are important to preserve and 
forecast supply. Iyengar et al. (2016) outlined important steps to minimize drug shortages, and 
their effects include recognizing the most at-risk drugs, establishing reporting systems for 
sharing information on current and emerging shortages, and enhancing medication supply chain 
data. Organizations have enormous data regarding supply chain. So much as organizations are 
looking to use the value of the data in order to make improved decisions such as establishing 
risk-based inspection scheduling, predictive of drug shortages.  
McKesson (2019) suggested predictive ordering (analysis) is a strategy that can improve 
hospital supply chain of pharmaceuticals by using data to track ordering habits. With the data, 
the percentage of manual ordering decreases while the focus of ordering standardization 
increases (McKesson, 2019). The use of predictive analytics may not be able to predict when a 
manufacturer’s supply of a drug is low, but they can be used as a tool for hospital supply chain 
managers to use in response to a pharmaceutical shortage. It has many strategic advantages as it 
makes it possible for a company to become the leader when the changes happen. As a part of the 
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supply chain, predictive analytics has not only focused on savings for pharmaceutical drug costs, 
but also on helping organizations with their long-term goal plans (Rafati & Poels, 2015). 
Predictive analytics can have a remarkable positive outcome in the supply chain of any size 
corporation. To remain competitive and relevant in today’s markets, it is essential to use the most 
useful front-line cutting-edge tools. For supply chain managers, looking to expand the adequacy 
of the present confounded supply chains, vital predictive analytics is a collection of learning that 
can help increment effectiveness and lessen costs (Parniangtong, 2016).  
Figure 1 
Conceptual Framework Model 
 
 
Discussion of Relationships Between Concepts  
The conceptual framework for this study builds on the understanding that exploring rising 
costs of hospital pharmaceutical shortages are essential for efficient patient care. All over the 
world, patient care profoundly relies on the fundamental components of pharmaceutical supplies. 
According to the World Health Organization (WHO, 2002), essential medicines are designed as 
products that serve the vital population health care needs at any time and should be readily 
available within healthcare organizations at an affordable cost. The following concepts serve as a 
foundation of this qualitative research study: the importance of hospital pharmaceutical 
Understand: The Importance Of 
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Efficiency.
Decrease: The Rising Costs Of 
Hospital Pharmaceutical Shortages.
Explore: Business Strategy And 
Predictive Analytics.
Optimize: Hospital Pharmaceutical 
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efficiency, rising costs of hospital pharmaceutical shortages, business strategy and predictive 
analytics, and hospital pharmaceutical demand management. 
Summary of the Conceptual Framework  
The components of the conceptual framework drew attention to the importance of 
hospital pharmaceuticals and the impact on patient care. The structure aligned the business 
process improvement suggestions and the relation with cost and sustaining quality care. 
Definition of Terms 
The focus of this study was the rising costs of hospital pharmaceutical shortages, the 
impact on patient care, and exploring the use of predictive analytics in New York area hospitals. 
The following terms are offered to explain the use in the research. 
Case study: A case study is one of the five qualitative research designs that intend to take 
a case and identify how the case demonstrates an issue or problem (Creswell, 2016). 
Healthcare forecasting: Healthcare forecasting has a vital role in an organization’s 
capability to develop and execute strategies for keeping up with the demands of the healthcare 
environment that is rapidly changing. The accuracy of data is what drives the decisions of 
healthcare leadership (Soyiri & Reidpath, 2013). “The use of the right forecasting tools can help 
leaders combat “future health events or situations such as demands for health services and 
healthcare needs” and facilitate preventative health strategies” (Soyiri & Reidpath, 2013, p. 6). 
Hospital pharmaceutical shortages: The Food and Drug Administration (FDA) defines a 
shortage in drugs as a certain amount of time (demand) that a drug that is medically necessary in 
the United States exceeds its supply (FDA, 2019). “They also consider a drug to be in shortage 
when supply issues affect how a pharmacy prepares or dispenses a drug product, or influence 
patient care when prescribers must use an alternative therapy” (FDA, 2019). According to the 
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WHO (2015), "Essential (critical) medicines are those that satisfy the priority health care needs 
of the population and are intended to be available at all times in adequate amounts in the 
appropriate dosage forms." The logistics of pharmaceuticals is the errand of attempting to put the 
correct medications and medicinal supplies, in the exact amounts, in the right conditions, at the 
correct service delivery points in facilities, at the opportune time, for the correct patients and for 
the accurate costs (Pinna et al., 2015). 
Pharmaceutical inventory management: Pharmacy inventory management is a 
complicated, however necessary procedure inside the healthcare system framework. Without 
sufficient practices for pharmacy, inventory management, hospitals risk not having the option to 
give patients the most proper medicine when it is generally required. Also, pharmacies' 
apportioning examples and medication determination decisions may directly affect the 
reasonableness of consideration (Bhakoo et al., 2012). 
Predictive analytics: A form of advanced analytics that uses historical and new 
information to forecast activity and to predict behavior and trend patterns (Coker, 2014). A 
variety of statistical methods are used in predictive analytics from “predictive modeling to 
machine learning to data mining, that analyze historical and current data to predict future or other 
unknown events. Predictive analytics have been widely used in many fields, including actuarial 
science, marketing, finance, retailing, health-care, and pharmaceutical research” (Hernandez & 
Zang, 2017). 
Qualitative Research Method: Pathak et al. (2013) specified that the focus of qualitative 
research is on understanding an investigation request as an optimistic or humanistic philosophy. 
Appreciation of the beliefs, conduct, interactions, and experiences, a qualitative method would 
be applied. Moreover, qualitative research concerns the description of written data, methodical 
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gathering, requesting interpretation that derives from the conversation, files, or perception (Miles 
& Huberman, 1994). 
Supply chain management: Supply chain management (SCM) is the effective 
administration of inventory activities to amplify client esteem and achieve a maintainable 
competitive advantage. It signifies a conscious effort by the supply chain organizations to create 
and run supply chains in the best and effective way possible. Supply chain activities include 
everything from product development, logistics, production, and sourcing, as well as the data 
systems needed to facilitate these exercises (Pérez-Salazar et al., 2017). 
Assumptions, Limitations, Delimitations 
To help readers understand the study, assumptions were covered to include thoughts of 
the researcher, but were not confirmed. Potential weaknesses of the study are covered discussed 
under limitations. The scope of the study and boundaries are represented in the delimitations. 
Assumptions  
 The qualitative case study had three essential assumptions. The first is that the researcher 
assumed she would be able to interview multiple pharmaceutical inventory leaders in a few New 
York hospitals. Interviewing the pharmaceutical leaders would be the ideal scenario, but maybe 
lower-level staff may have more direct experience. The initial contact may be with the 
pharmaceutical inventory leadership who may connect the researcher with the more appropriate 
staff. The second assumption is that there will still be viable information gathered from the study 
from hospitals that may have already implemented predictive analytics. Moreover, if a hospital 
already uses predictive analytics, is it beneficial for the rising costs of hospital pharmaceutical 
shortages. Thirdly, the assumptions included in this qualitative case study were that the research 
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experiences would be relevant to other rising costs of hospital pharmaceutical shortages in New 
York hospitals that were not surveyed in this study.  
Limitations  
 The limitations of this qualitative study included the selection of New York Hospitals. 
The interviewed hospital leaders are a small number and may only have experience in what their 
respective facilities use in terms of hospital pharmaceutical shortages. Additional limitations of 
this study are the lack of generalization because of the limited number of participants in the 
study. Qualitative research and case study design are problematic when identifying the correct 
number of participants and cases (Creswell & Poth, 2108). There was also the potential to gather 
data that were not accurate, and limitations can be reduced by the implementation of 
triangulation of data from more than just the pharmaceutical inventory management leader in a 
few New York hospitals and the pharmaceutical non-management staff.  
Delimitations  
The scope of this qualitative case study was the experience with hospital pharmaceutical 
shortages and the effect on patient care. This study was based upon the experiences of just a few 
New York hospitals, and the remaining hospitals in New York are outside of this study. 
Additionally, there are many types of hospital inventory management; however, this study 
focuses on pharmaceuticals. Any other inventory management areas in the hospitals are outside 
of the scope of this study. The main research question arose from the problems faced by New 
York hospitals with the increasing costs of prescription shortages in hospitals and the effect on 
patient care. The study covers only a few New York-based hospitals, where only senior 
pharmaceutical leadership will be interviewed. The outer limits would also include if any other 
supply chain process other than predictive analytics will be explored.  
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Significance of the Study 
The significance of this study provided results for individuals that would like to improve 
the hospital pharmaceutical shortages that will ultimately improve patient care by exploring the 
use of predictive analysis. Aptel and Pourjalali (2001) stated that one of the most important 
healthcare industry management healthcare issues is the management of pharmaceutical 
inventory. Aptel and Pourjalali (2001) stated that one of the most important healthcare industry 
management healthcare issues is the management of pharmaceutical inventory. Consequently, 
careful management of hospital pharmaceuticals is straightforwardly identified with a nation's 
capacity to address healthcare concerns. The study was also significant because it included 
biblical integration of inventory, supply chain, pharmaceuticals, and predictive analytics. 
Additionally, the study was significant because it progresses knowledge in the cognate field of 
Strategic Management.  
Reduction of Gaps  
 The significance of this qualitative study was that the data would add to the existing body 
of knowledge and effective practice of business describing the importance of implementing a 
predictive analytics system, to pharmaceutical inventory management in New York area 
hospitals. Utilizing systems to improve workflow and lessen wastes has resulted in missing doses 
reduction, expense savings, and reductions in patient-specific waste, medication mistakes, 
medication processing times, pharmacist confirmation time, product confirmation time, and the 
tie associated with the delivery of medication (Shiu & Mysak, 2017). 
Implications for Biblical Integration  
 This study explored the rising costs of hospital pharmaceutical shortages, the impact on 
patient care, and the use of predictive analytics in New York area hospitals. "The Lord God took 
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the man and put him in the Garden of Eden to work it and keep it." —Genesis 2:15, God made us 
work. Not in an aggressive sense to make his offering or face his fury. Yet, to subdue the earth 
and have domain over each living animal (Gen. 1:28). As it were, all of life, culture, and work is 
to mirror the magnificence and brilliance of God. This is an accentuation of sacred texts about 
work all through the Bible. One of the great promised that God gave to us is the promise of 
supplying our needs. "And my God will supply all your needs according to His riches in glory in 
Christ Jesus" (Philippians 4:19). The scripture tells us to be content with the provisions of God. 
God typically works through natural methods in his supply chain with individuals acting steadily, 
ingeniously, and liberally in doing their part. We ought not exclusively to be an end connected in 
this chain as beneficiaries; however, we should work as different links also.  
In Genesis, Joseph was on an advance track to promotions, due to his logistical planning 
and forecasting gift. He climbed quickly from the role of superintendent/prisoner in an Egyptian 
correctional facility to Pharaoh's Chief Logistics Officer with "Prince" in his title. At the 
pinnacle of his vocation, the man was second just to Pharaoh. Indeed, even there, Joseph's 
initiative characteristics shone through: "And the attendant of the jail focused on Joseph's hand 
every one of the detainees" (Genesis 39:22). What is less known, be that as it may, is that during 
his years in jail, Joseph aced forecasting systems, translating the dreams of Pharaoh's previous 
Chief Butler and Chief Baker. The two translations were acknowledged, establishing Joseph's 
notoriety for being an ace forecaster. 
Moreover, the change that happens through the Holy Spirit enables people to forfeit 
oneself for the consideration and sympathy of others. For instance, if a pharmacist is completely 
versed in God's Word and is being changed into the similarity of Christ regularly, yet has not 
been keeping up current information and comprehension of new medication treatment or 
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treatment rules, at that point the consideration of the patient will be lacking. The most minding, 
sympathetic, Christ-like individual should, in any case, have the vital aptitudes and learning to 
convey proper drug specialist care. Then again, a drug specialist who is noted in their forte will 
be unable to give the essential route of moral choices, or even think to forfeit their solace, to 
think about others without the continuous recharging of their brain through the spirit-coordinated 
investigation of Scripture (Sweeney, 2011b).  
Relationship to Field of Study  
Strategic management was the researcher’s field of study. A key part of the business 
strategy is characterizing the minute of opportunity for executing this strategy before competitors 
do likewise (Meredith & Shafer, 2016). The business strategy of an organization incorporates a 
collection of plans, policies, and strategies for the organization to compete efficiently in its 
industries. Fundamentally, the organization’s strategy indicates the competitive advantage of an 
organization will be and how this ideal place will be achieved and supported through the 
selections the organization's business units make later. Inventory management works at three 
measurements: strategic, tactical, and operational. At the strategic dimension, an organization 
settles on a suitable choice within the supply chain that is important to the organization.  
In the case of the rising costs of hospital pharmaceutical shortages and the impact on 
patient care, on a global level, pharmaceutical administrations are confronting difficulties like 
worldwide quality values, patent expiries, healthcare reform, and increased standard 
requirements. To address these difficulties, pharmaceutical firms have to improve speed to 
market, decrease costs, and increase responsiveness. Shah (2004) characterized the key issues 
that assume a significant job in the structure and advancement of the pharmaceutical supply 
chain such as development improvement, process improvement, capacity planning, and plant 
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design. The strategic management decisions will cover the expansiveness of the supply chain. 
These choices depend on the healthcare customers, wholesalers, logistics, manufacturing, and 
product development. Furthermore, such critical decisions should embody the organization’s 
corporate strategy that is already in existence (Stanger, 2013). 
Summary of the Significance of the Study  
The significance of the study revealed how some of the gaps in literature can be reduced. 
It also presented the integration of biblical implications relating to the rising costs of hospital 
pharmaceutical shortages and the impact on patient care. Finally, the significance of the study 
demonstrated the relationship of the study to the researcher’s cognate, strategic management.  
A Review of the Professional and Academic Literature 
For the qualitative study, the following literature review examined the rising cost of 
hospital pharmaceutical shortages and the impact on patient care: exploring the use of predictive 
analytics in New York hospitals. The literature review will be a compilation of scholarly peer-
reviewed journals published within the last five years, along with books, textbooks, and other 
source literature that gives insight on the business problem and proposed solution. The literature 
review started with an introduction to the overall business problem relating to the field of study. 
The next part of the literature review discuss discusses five main headings: 
1. The foundation of the United States healthcare system,  
2. The origin of supply chain management, 
3. The current state of healthcare industry challenges,  
4. Hospital pharmaceutical supply and demand management  
5. The history of predictive analytics. 
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Overall Business Problem 
Rising Costs of Hospital Pharmaceutical Shortages. According to the Pharmacy 
Times, the cost of prescription drugs remains a problem for policymakers, patients, and 
providers, and pharmacists may play a vital role in ensuring patients have access to the care they 
need (Marotta, 2019). Kesselheim et al. (2016) stated that in the United States, policymakers, 
payers, and patients are concerned about the increasing cost of pharmaceutical shortages. 
Increasing drug costs not only contribute to healthcare spending but can also have implications 
clinically. Patients have to pay higher co-payments for pharmaceuticals because of cost-
containment. If pharmaceutical prices continue to rise, the ability to afford the drugs could 
lessen, which will result in harmful patient health outcomes. When it comes to drug shortages, 
there is no warning system; however, the U.S. Food and Drug Administration (FDA) enacted 
federal legislation, which requires manufacturers to report drug shortage (FDA, 2019). It is not 
easy to predict drug shortages, mainly because of manufacturing’s possessive lack of 
transparency.  
Hospitals can track reports from the FDA, but there is no actionable information available 
to them. Production-related problems are causes for medical shortages. As with raw material 
shortages, production concerns were considered a common cause of global shortages. Production 
issues have far more significant effects on the quality of medicinal products (Heiskanen et al., 
2017). Uthayakumar and Priyan (2013) stated in years past, hospitals and health systems viewed 
the pharmacy as more of a transactional role. However, recent findings demonstrate that hospital 
pharmaceutical shortages are an essential part of patient results. Pharmaceutical deficiency 
compromises the safety of patients and surges the liability of the health care system inclusively. 
Improving the service level for patients in the pharmaceutical business setting is a noteworthy 
24 
 
undertaking towards a socially mindful supply chain. To address these difficulties and enhance 
the manufacturer capacities, hospitals are confronting the requirement for a solution in inventory 
management. Inventory management alludes to the procedure of requesting, warehousing, and 
controlling organizations' inventory of components and raw materials. Furthermore, inventory 
management enables hospital pharmaceuticals to restock certain things, the measure of 
procurement, and the costs to pay (Hematologic et al., 2018). High standards for managing 
pharmaceutical inventories are necessary. According to Volland et al. (2017), pharmaceutical 
inventory management contrasts from other medical item classes dependent on their particular 
attributes. Nevertheless, pharmaceutical inventory management has been recognized as one key 
switch to acknowledge proficiency improvements without adversely influencing the care of 
patients.  
According to Cohen (2019), the impact on human health is excellent when it comes to 
supply chain management. Patients need accurate and required pharmaceutical supplies to 
maintain optimal health. Adverse effects, including death, are the result of out-of-stock medicine 
or medication errors from dispensing to the wrong patient. Kohn et al. (2000) reported that close 
to $2 billion is the annual cost associated with 7,000 deaths caused by an estimated one million 
medication errors a year. According to the American Journal of Health-System Pharmacy (2017), 
pharmaceutical shortages are mostly the outcome of quality issues during the manufacturing 
process, resulting in a production stop to address the issue. Other businesses cannot absorb this 
disruption in production in the case of a product with few competitors, and demand outperforms 
supply, stemming in a shortage. There are no alternatives for output in the case of a sole-source 
manufacturer, and hospitals must either compound a drug as far as possible, fight to obtain a 
drug supply, or suggest an alternative therapy if there is one (ASHP, 2017).  
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In December 2019, the world learned about the Coronavirus disease (COVID-19). An 
infectious disease caused by a newly discovered coronavirus. This disease was initially in Wuhan 
City, Hubei Province of China (WHO, 2020). At the time, there were many unknowns about 
COVID-19. However, the world would soon come to know the seriousness of this disease and 
the impact it would have on the world, healthcare, and pertinent to this study, healthcare 
pharmaceutical supply chain. 
The United States Healthcare System 
Foundation. Healthcare is an interrelationship among those in the United States who 
receive, provide, and finance healthcare. Health care affects all, including the healthy, the 
sometimes sick, and those with severe illness. Medicine covers procedures as varied as 
pregnancy, cosmetic surgery, chronic disease treatment support, and end-of-life hospice care 
(Moses et al., 2013). In the early days of the colonies, medical care was hard to come by, as few 
British trained doctors came to North America (Moses et al., 2013). 
However, by the mid-eighteenth century, the first significant hospitals had been founded 
by New Orleans, Philadelphia, and New York, and the primary medical schools had opened. 
During the United States Civil war, the federal government and individual states began building 
hospitals for sick and wounded soldiers in each state. Public health initiatives such as clean 
water, sanitation facilities, and tuberculosis control were also introduced by the state, which 
began to have a significant effect in the early twentieth century. Health care has since expanded 
in the U.S. (Moses et al., 2013). Health care services in the United States are largely private. 
Many of the practices of this system are based on American culture's beliefs and values (Shi & 
Singh, 2018). Wolinsky (1988) reported that the idea of health and healthcare in the United 
States have mostly been administered by the biomedical model, which is a part of the medical 
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model. The medical model describes health as being free from illness or disease. The medical 
model also draws medical diagnosis and intervention as tools to treat infections.  
Healthcare delivery is medically caring for patients that are ill (Wolinsky, 1988, p. 76). 
The U.S. health care system is not universally accessible. The U.S. health care system is 
considered a patchwork of broken services that are privately and publicly supported. Insured 
Americans are insured by both available and private insurance care, which is provided and 
protected by the place of employment of a person. Federal funds provide Medicare and Medicaid 
coverage for the poorest people. The government also publicly funds Indian Health Care and the 
Military (Shi & Singh, 2018). According to Beamesderfer and Ranji (2012), although there is 
much debate on the leading cause of increasing U.S. health care prices, the expert has identified 
three causal factors. The first factor is the cost of prescriptions and innovations. Healthcare 
spending for development costs is fueled by high-level requirement and drugs that intensely 
generate more demand even when not necessarily cost-effective. The second factor is the rising 
costs for chronic disease treatment. Treatments for illnesses, such as diabetes, are high because 
of maintenance while on the medication. 
Additionally, health care costs are on the rise for the end of life care. The more persistent 
a disease, the higher the fees, particularly with many repeated admissions (Dartmouth Atlas of 
Care, 2013). The last factor reported by Kelin (2009) is the cost associated with administration. 
The U.S. surpasses all other industrial countries in the prices of insurance administration. The 
differences between private and public administration are hard to determine because of the broad 
scope of defining administration. 
History of Healthcare Industry Operations. Shi and Singh (2018) stated that one of the 
fastest growing and most prominent industries in the world is healthcare. Also referred to as the 
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medical industry, healthcare is the coordination of divisions that gives service and goods to treat 
patients by rehabilitative, therapeutic, palliative, and preventive care. The healthcare industry in 
the United States embodies a substantial paradox of low effectiveness and high expenditures. 
The healthcare situation in the United States is not ideal even for those who may have insurance 
through their jobs, or savings, or are considered underserved. Because there is no worldwide 
provider of healthcare and healthcare insurance in the United States, many healthcare 
organizations use piece work to cover various population subgroups. Social and health services 
strategies are more incorporated in other nations than they are in the United States. According to 
Phillips (2012), since medical care systems and public health are incorporated into a consolidated 
health system, various countries differ from the United States. 
The Affordable Care Act (ACA) was signed into law in 2010 by President Barack 
Obama. The purpose of this act was to regulate the health industry, reduce the costs of 
healthcare, improve the healthcare service, and healthcare insurance. The ACA established 
exchanges where people could shop for insurance as a way to steady insurance markets. To 
lessen cost and improve quality, the ACA energized the production of accountable care 
associations, whereby professionals in healthcare and healthcare centers would offer composed 
consideration to Medicare recipients. To pay for changes, the ACA exhausted high-advantage 
plans and medical devices, while diminishing Medicare spending (Blumenthal et al., 2015). 
Gostin et al. (2017) reported that in 2014, the ACA law drew criticism because of the 
website launch failure. More recently, buyers have communicated worry about limited systems, 
high deductibles, and premium spikes. The individual command has not been adequately viable 
at getting sound people to select, and some significant safety net providers have pulled back from 
trades. The ACA has impressively extended access, with more than 20 million people picking up 
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inclusion—60% through Medicaid. By 2014, the ACA protected people with pre-existing 
conditions to not face premium increases and access to insurance for those who could not get 
coverage before the ACA was made possible. The law had some flaws, and there is much 
pressure to cut costs and improve quality within the healthcare organizations (Blumenthal et al., 
2015).  
Beamesderfer and Ranji (2012) stated that many of the best research facilities and 
hospitals in the world are in the United States. The Mayo Clinic, Cleveland Clinic, Johns 
Hopkins Hospital, UCLA Medical Center, and Massachusetts General Hospital are among their 
top referral facilities. The U.S. is also considered one of the best cancer treatments, heart care, 
and orthopedic medicine destinations in the world. There are a wide variety of public and private 
hospitals, emergency care clinics, surgery centers, and specialty clinics in major cities. Care 
costs are fueled by high-level requirements and drugs that are more restricted in smaller 
communities and can include everything from a county hospital, a community care facility run 
by nurse practitioners, to telehealth facilities. 
Current State of Hospital Operations. The current state of hospital operations has 
thrown various health-related difficulties for individuals over the globe and the residents. The 
government offices and the healthcare industry are especially worried about the human services 
related issues and the proactive measures to be taken to improve the health services situation. 
According to Filser et al. (2017), to stay competitive, businesses must continuously improve their 
services. In the case of healthcare, it makes even more sense to improve business processes for 
increased health and well-being. To effectively control the healthcare system, hospital operations 
concentrate on achieving the following objectives: improving the quality of facilities, improving 
the reliability of procedures, reducing medication mistakes, using analytical data and business 
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intelligence, enhancing clinical viability, and improving patient experience. To accomplish these 
objectives, the administration and medical clinic staff ought to perform different complex 
errands by keeping pace with the dynamic healthcare condition, including the administrative 
changes. The multifaceted nature expands given the nature and volumes of patients, growing 
supply costs, stringent government compliances, quality necessities, various use of benefits, and 
lastly, the shortage of prepared staff. 
Healthcare operations have changed over the years, with a greater emphasis on leading 
technologies and trends. In 2017, Becker’s Hospital Review featured an article of four trends 
leading advances in today’s health care operations (Laing, 2017). The first trend is data and how 
data drives decisions in any business, especially healthcare operations. Using data can give an 
organization the tools to make decisions about an organization's financial and performance 
health. Laing (2017) stated that finding the most cost-effective and efficient data is challenging 
when capturing and reporting day to day operational data. A data-driven organization 
management tool may encourage the use of data to control compliance-based inspections, testing 
and reporting on facility maintenance, rounding to improve the care climate, and patient 
preparedness and treatment (Laing, 2017). Additionally, efficient data can help manage capital 
planning and operations budgeting for the healthcare facility or any other organization. 
A hospital’s preparation in emergency preparedness is the second trend of healthcare 
operations today. Hospitals are used to minor injuries and mishaps caused by the elements but 
are they prepared for difficult situations, such as major disasters and mass casualties. The 
Centers for Medicare and Medicaid Services (CMS) suggests that hospitals should participate in 
hazard identification, hazard mitigation, response, and recovery safety management programs 
(CMS, 2019). The third trend is maintaining an efficient environment of care for patients. It is 
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crucial that patients feel they are empowered and consumers of their health. They are improving 
the patient experiences and fostering patient engagement. Using innovations such as social 
media, online reviews, journals, and more can provide patients with quick access to online 
surveys, price transparency, and care assessments, adds to this shift – from patients to consumers 
(Laing, 2017). 
The fourth trend, which directly relates to this research is the focus on cost reductions not 
only for pharmaceutical but for healthcare operations as a whole. Hospitals look for ways to trim 
costs all of the time. Whether it is labor, materials, assets, capital, or pharmaceuticals, a hospital 
should have a good sense of their expenditures. There should be a sound system in place to 
record the costs and be a tool for future forecasting and financial planning. Hospitals will 
reassess what they are spending on hidden-savings materials (Laing, 2017). More patients are 
now using more drugs designed for a high annual aggregate cost. Rising pharmaceutical 
expenses, particularly the presentation of excessively high expense drugs, are likewise added to 
more significant expense structures to U.S. health care.  
The latest epidemic, now a pandemic, Coronavirus (COVID-19), has greatly impacted 
existing operations in hospitals. In China, COVID-19 is considered a respiratory disease 
outbreak. The disease frequently travels across the globe and is now present both internationally 
and domestically. Though coronavirus continues to spread in the United States, hospitals are 
bracing for the inflow of patients who need care for the worst effects of the disease it causes, 
COVID-19. The World Health Organization's (WHO) International Health Regulations 
Emergency Committee declared the outbreak a Public Health Emergency of International 
significance (PHEIC), in January 2020. On January 31, Alex M. Azar II, the Secretary of Health 
and Human Services, declared a public health emergency (PHE) for the United States to help the 
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nation respond to COVID-19. On March 11, the WHO publicly described COVID-19 as a 
pandemic. The US President declared the "COVID-19 outbreak a national emergency" on March 
13, 2020 (CDC, 2020). The spread of the coronavirus outbreak is daunting in the health care 
systems of countries like China and South Korea, which are heavily involved. In those nations, 
the ongoing increase of infected patients has reportedly overflowed hospital beds and lengthy 
delays of treatment for other health conditions. The entire clinical future concerning COVID-19 
is not entirely understood. Recorded diseases ranged from very mild (including those with no 
documented symptoms) to severe, including death-induced illness. 
Supply Chain Management (SCM) 
Origin of Supply Chain Management. In 1982, in an interview for the Financial Times, 
Keith Oliver, a Booz Allen Hamilton consultant, introduced the term "supply chain 
management" to the public domain (Handfield & Nichols, 1999). According to Simchi-Levi et 
al. (2008), Supply Chain Management (SCM) primarily includes the flow of services and goods. 
SCM includes all the steps involved in the sourcing of raw materials to the finished goods in a 
manner that is organized and provides value to the consumer. SCM is a distributor effort to 
develop and execute supply chains that are as reliable and cost-effective as possible. SCM 
derives on the idea that the activities of various organizations that make up a supply chain are the 
consequence of almost any product that comes to market. While supply chains have existed for 
years, many businesses have paid attention to them as a value-added to their operations only 
recently. According to Kozlenkova et al. (2015), SCM practice draws heavily from the fields of 
operations management, logistics, procurement, IT, marketing, industrial engineering, and 
systems engineering. Moreover, SCM seeks an integrated approach. 
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As per Beamon (1998), organizations use supply chains to provide them with what is 
needed to flourish and survive. Each organization has a role to play in one or more of its supply 
chains. Organizations need to learn to match their supply chains with the needs of the customers 
they represent to thrive in the competitive markets that make up the economy of today. It was in 
the 1980s when organizations exposed new business systems to thrive in the competitor markets 
and reduce costs. Beamon (1998) also stated the present interest sought to expand the 
conventional supply chain to include reverse logistics, including material recovery for reuse, re-
production, and reuse purposes. The supply chain theory originated mainly in industrial science 
from two-stage multi-echelon storage models, and it is important to note that there has been 
significant progress in the development and evaluation of two-echelon structures. 
If there is a lack of effective supply chain management, there will also be a decrease in 
market share and profits. The advancement of supply chain management in the last twenty years 
has been mainly motivated to reduce inventory management. Supply Chain Management 
represents the organization of a business's functions relating to manufacturing, distribution, and 
sourcing of service and products and logistics. From a practical point of view, the supply chain 
theory has arisen from several changes in the manufacturing environment, including increasing 
manufacturing costs, limited manufacturing bases capital, shortened product life cycles, 
manufacturing playing field leveling, and business economies globalization (Ellram & Cooper, 
2014).  
Current State of Supply Chain Management. Varsei (2016) claimed all around the 
world, supply chains are being transformed. Transportation, warehousing, and metrics that will 
affect a company would represent the current state of the global supply chain. Technology, 
external pressure, and the internal transformation of the nature of their future supply chain are 
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pushing companies to do so. Supply chain management of today leans on service as a strategic 
discipline, which is progress from logistics operations and procurement. Management of the 
traditional supply chain focuses on price, time, efficiency, social, and environmental dimensions. 
This approach is often part of a response to legal requirements or consumer demands. 
Nonetheless, businesses are gradually moving outside adaptation by considering, as part of a 
constructive approach, that taking into account social and environmental factors in supply chain 
management brings a vital strategic benefit to the competitiveness of the business (Bentahar & 
Benzidia, 2018).  
Reefke and Sundaram (2016) noted that in the present trend of growing competition and 
globalization, the strategic management of stakeholders, both internal and external, from the 
suppliers of raw products to the end-users, is the essential focus for the supply chain 
management. Supply chain management is, therefore, very well placed as a convincing 
management technique for associations' sustainability success. Supply chain management 
encourages a mix between the client base, the network distribution and, exercises internal to 
firms and the supply base.  
Scholten and Schilder (2015) noted in current and future years, technology and 
challenges will follow the supply chain. Technologies will give more options for warehouse 
management, especially in automation. Increasing capacity will continue, and organizations will 
have to find ways to cut costs to retain customers. Organizations will also have to improve their 
competitive advantage to keep up with the broader distribution business such as Amazon. 
Enhancing technology also brings more security risks, and organizations will have to strengthen 
risk management to protect manufacturers and their customers. According to Scholten and 
Schilder (2015), in the current complex business environment that requests global but flexible 
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operations and lean concepts, organizations are even more susceptible to the risks and disruption 
of supply chain systems. It is a fundamental empowering influence of acquiring ongoing 
knowledge into generation execution, enabling makers to recognize issues and resolve them with 
insignificant expense and interruption. 
The current state of supply chain management is profoundly affected by the pandemic of 
the Coronavirus (COVID-19). The spread of the latest coronavirus, COVID-19, is felt across 
operations worldwide in ways that are difficult to model and measure. The areas affected are 
central to many global supply chains. There is a lack of hard information; concerns are mounting 
about depleting (or idling) stock; and businesses worry that they will not meet contractual 
obligations in due time (PWC, 2020). Businesses need to act on several fronts at once. While 
trying to secure the health of their employees, they also need to safeguard their operational 
stability, now increasingly under threat from a historic supply- chain blow (Alicke et al., 2020). 
While procurement teams are struggling to deal with the global pandemic of COVID-19, most of 
them have struggled to keep up with the reports of global response initiatives (Choi et al., 2020). 
Role of Supply Change Management in Healthcare. Mandal and Jha (2018) stated that 
healthcare supply chain management involves getting assets, overseeing supplies, and conveying 
products and enterprises to suppliers and patients. To finish the procedure, physical merchandise 
and data about medicinal items and administrations, for the most part, experience various 
autonomous partners, including producers, insurance agencies, hospitals, suppliers, and a few 
administrative offices. Nevertheless, by endorsing efficiency in the healthcare supply chain, 
hospitals and doctor practices can make significant cost-diminishing decisions within their 
organization. The objective of the healthcare supply chain is to find the liabilities among 
divisions and prescribe measures to decrease them. The upsides of capable healthcare supply 
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chain are improved systems, gainful use of advantages, employees that are engaged, effective 
treatment, and fulfilled patients. Numerous clinics of today are encountering an expansion in 
supply chain inefficiencies, which is bringing about financial losses and wasteful aspects which 
influence the organizations bottom line (Sweeney et al., 2018).  
The supply chain ensures the real connection of the financial cycle, medicinal services 
activities, and emergency clinic, divisions. One may define the supply chain as running a back-
end system, which is imperative to tie together all the various methods. The clinically integrated 
supply chain is transforming the way human services provide academically developed centers 
around the world (Jacobs & Subramanian, 2012). Leaders in healthcare are by and by planning to 
show sound fiscal stewardship by looking much more cautiously at hospital inventory, and how 
to manage the supply chain to help balance supply and demand. Hospitals need to deal with 
upstream supplier trades, and downstream patient demands to handle the supply chain process 
effectively. Moreover, this places a hospital in a position to strike a balance between meeting 
patients’ needs, which are often difficult to calculate with precision or consistency, and ensuring 
a sufficient supply of materials and supplies. It is essential to set up a policy framework that 
empowers health care organizations and hospitals to update and benefit from technologies that 
are being developed for ideal inventory management systems. 
While there is bounteous research in the supply chain, only from time to time have the 
proposed techniques discovered their way into execution in real emergency clinic settings 
(Rosales et al., 2014). Having the correct items accessible at the purpose of utilization is 
imperative to the proficient and viable treatment of patients. With the regularly expanding 
demand for items, it ends up testing to oversee inventory in a dynamic office, for example, at a 
hospital. Additionally, according to Moons et al. (2019), management of hospital inventory is an 
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essential area of a supply chain system. In a medical clinic environment, where it is a prime 
concern to express excellent patient care, inventory management is not a priority. Current 
strategies used to lead a supply chain execution that is imperfect include bringing about 
something over the top or too short of inventory in stock, additional time work to oversee 
supplies, sped up shipments and, conceivably inadequate nature of consideration conveyed to 
patients. 
Healthcare Industry Challenges 
Current State of Healthcare Challenges. According to the American Colleges of 
Healthcare Executives (ACHE), the top challenges for hospital operations in 2018 include 
financial challenges, government mandates, quality and safety for patients, personnel shortages 
(ACHE, 2018). The healthcare industry has risen as one of the most significant social and 
financial issues in the nation. While the prior decade concentrated primarily on the installment 
and lawful changes that would be required to move the healthcare industry forward, the recent 
focus has been progressively about how the private segment has reacted and moved to answer 
new challenges. Some of the pressing challenges in healthcare include the delivery of healthcare 
relating to planning and scheduling, issues with allocation resources, healthcare logistics, 
healthcare information, and costs and pricing problems in service delivery (Soares de Mello et 
al., 2015).  
Abelson (2016) reported another significant change is the business move to overseeing 
wellbeing along a continuum as opposed to treating individuals at the emergency clinic when a 
medical problem happens. This point of view begins with a preventive drug to keep individuals 
healthier, so they need fewer hospital services. At the point when they do become ill, this new 
model consolidates remote patient observing after treatment to enable them to recuperate all the 
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more rapidly and limit re-admissions. The continuum-wide emphasis on wellbeing and treatment 
leads healthcare providers to explore value-based care systems that quantify outcomes and step 
away from the traditional fee-for-service model. The outgrowth of this is population health 
management, which searches for findings to be feasible for communities rather than people and 
relies heavily on business intelligence and data analysis. 
Healthcare also faces a complex and complicated supply chain management as a client, 
and in this case, the consumer relies heavily on pharmaceutical inventories as part of their care 
standard (Moons et al., 2019). A hospital’s perspective of success includes operational 
efficiency. Properly utilizing resources to improve care and lower costs is an increased challenge 
that many hospitals face. By diminishing bottlenecks and executing strategies that will drive 
compelling answers for fundamental issues, any business can flourish. Healthcare organizational 
leadership should expect to encounter challenges, including policy changes, ethical issues, 
therapeutic and innovative advancements, and regulatory challenges over the next five to ten 
years (Teel, 2018). Healthcare spending will continue to rise, and leaders must find different 
tools to battle the rising costs. 
Coronavirus (COVID-19) is one of the most serious and widespread of recent global 
outbreaks. It is also becoming evident that the impact on COVID-19 on health and care systems 
goes beyond the disease; this is because health systems still have to deal with the current rates of 
non-communicable diseases (Alessi, 2020). Although China was the epicenter, the effect was 
global, affecting health care, infecting people, impacting travel, and disrupting supply chains 
around the world. In the United States, New York has become an epicenter. The Governor of 
New York states that spatial closeness makes residents vulnerable (Levenson, 2020). There is the 
need for health care systems to ensure sufficient funding for expenditure in health care services, 
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the suitable proof equipment in hospitals and emergency departments, the enhancement of 
accessibility in intensive care units, the rise in the ratio of the number of ICU beds to the total 
number of hospital beds (Smereka & Szarpak, 2020). 
Hospital Inventory Management Challenges. Satisfying a hospital's medical needs 
requires supplied medications and other supplies to function. Pharmaceuticals required by 
inpatients; doctors use pads, masks, and equipment while surgery is performed; similarly, 
hospitals also provide outside patients with unique drugs, like those used to treat diseases such as 
AIDS and cancer that are not available in retail pharmacies (Maestre et al., 2018). Hospitals are 
concentrating more on the supply chain because of an increase in reimbursement and pressure 
from competitors. The use of organizational process improvements is explored to reduce 
operations costs and sustain quality care. The area with the most significant impact on costs and 
efficiency is hospital inventory management. The sooner a drug shortage is determined, hospitals 
will be able to plan accordingly for a patient's safety. However, pharmacies are aware of 
shortages once they cannot get a requested drug (Rich, 2013). Late notification puts a hospital in 
a crisis mode, and at that moment, the best decisions are made for a patient's wellbeing. One of 
the internal supply chain's weaknesses is the lack of space and visibility at the point of use for 
hospital inventory products (Rosales et al., 2019).  
Hospital inventory needs to be tracked, guarded, and accessible at all times. Hospital 
inventory is not as easy as every patient requires a different product or service. Hospital 
inventory is also faced with the fluctuation to respond to a specific demand at a particular time. 
Shelf life becomes an issue when there is no control over temperature. If there is no protection or 
organized system for complex inventory, hospitals may incur higher costs for expired medicine 
or stockpiles. Additionally, the challenge of hospital inventory security can cause legal and 
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safety issues for the organization. There are too many instances where inventory is stolen or 
tampered with (Zepeda et al., 2015). The recent pandemic of COVID-19 brings hospital 
inventory challenges (Swerdlow & Finelli, 2020). Hospitals will track the level of equipment to 
ensure sufficient availability of personal protective equipment for those on the front lines. They 
will need to engage in hospital protection to prevent theft or hoarding of such equipment. 
Extended use or restricted reuse of N95 respirators can become essential, and communication is 
crucial about preservation. Then, supply shortages are likely, where supply may be reduced 
depending on other countries suffering similar outbreaks. Most N95 respirators are made either 
in China or in the USA. When COVID-19 begins to spread, the hospitals will find it difficult to 
get more supplies (Hutchins & Smith, 2020). 
Rising Costs of Hospital Pharmaceutical Shortages. Two of the primary issues leading 
to drug shortages are related to manufacturing quality and forecasting errors. Baumer et al. 
(2004) claimed pharmacists and physicians have expressed growing concerns about shortages of 
products since 1999. Threats to the U.S. pharmaceutical supply chain's reputation, like short-
term drug usage, will sound an alarm across the medical community. Health care professionals 
are required to allocate and even restrict limited supplies of certain medications carefully. 
Pharmacists cannot explain such procedure changes with prescribers and suggest substitute 
therapies (Baumer et al., 2004). Drug shortages and sudden price increases are the two most 
challenging issues for hospitals pharmaceutical supply chain (Fox & Tyler, 2017). Over the past 
ten years, shortages have impacted the rising prices of pharmaceuticals. In a national survey of 
the impact of drug shortages on U.S. health systems, three-drug shortages, in particular, have 
been identified as affecting more than 80 percent of responding institutions, namely epinephrine 
syringes, dextrose 50 percent syringes, and succinylcholine (Kaakeh et al., 2011).  
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When a drug is not available commercially to meet the patient demand, a shortage occurs. 
Insufficient quantity and total unavailability of drugs threaten the quality of care for patients. 
While many shortages can be handled efficiently, there is often a need for substantial staff 
resources to recognize available substitute products or medically equivalent agents and to ensure 
that organizational changes are made to accommodate product transition (Kaakeh et al., 2011). 
Pharmaceuticals’ used in hospital critical care unit costs are on the rise for a few reasons. 
Multidisciplinary labor efforts are required to research the market, discuss and research 
alternative effective and safe strategies, make operational changes, communicate these findings, 
and then make appropriate changes again once the shortage has resolved. Hospitals bear a heavy 
financial burden when the expense of pharmaceuticals increases and must settle on final 
decisions about allocating limited resources.  
Managing these costs requires making difficult choices between providing adequate 
salaries to staff members, many of whom are highly talented in shortage professions; purchasing 
new technology to upgrade care facilities; or paying for pharmaceuticals, especially if these 
increases are not linked to new therapies or improved patient outcomes (AHA, 2019). With little 
to no warning, rapid price spikes, and medication shortages, all of them are increasing, and 
patient care would be drastically affected (Fox & Tyler, 2017). According to Flannery et al. 
(2017), drug shortages, changes in device regulations, generic manufacturer concerns are some 
of the reasons affecting the costs in critical care. “In a descriptive analysis of pharmacotherapy in 
the ICU, medications averaged 38% of the hospital’s total drug expenses and increased by an 
average of 12% per year” (p. 54). Pharmacists also spend a great deal of time consulting with 
suppliers and wholesalers, training facilities workers on substitute drugs, creating or changing 
policies or medical recommendations, and reviewing digital databases and medication 
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management systems. Though the pharmacy department often plays a leading role in managing 
drug shortages, it is essential to collaborate with all healthcare providers affected by the shortage 
(Kaakeh et al., 2011). LaPointe (2020) argued hospital drug shortages in the United States before 
COVID-19 (the novel coronavirus) were a persistent, recurrent epidemic with no end in sight. 
History demonstrates that isolated natural disasters can have drastic, long-term effects on the 
supply chain of pharmacy products. Now, COVID-19's global effect is likely to exacerbate the 
situation considerably. Lockdowns in China and Europe have disrupted development. Such 
countries, where most generic drugs are produced, have been slashing exports recently to 
maintain sufficient local supply. COVID-19 is spreading through the United States, forcing 
hospitals to increase their bed capacities. When health-care providers fill these beds with the 
sickest and most vulnerable patients, we will fully anticipate the demand for life-saving drugs to 
increase (Yoder, 2020). It is also uncertain how much COVID-19 would cost hospitals. Providers 
are still at the height of the pandemic, but one thing is sure, because of the high price tag that 
COVID-19 carries, there will be financial problems for many hospitals for years to come 
(LaPointe, 2020). 
Forecasting Errors. The challenge of forecasting variables makes it impossible to 
produce 100 percent correct forecasts. Pirc et al. (2016) stated there will still be an unpredictable 
deviation, despite the best efforts. However, ensuring the proper supply of drugs at an 
appropriate price involves forecasting that has adequate certainty about funding and timing of 
orders to allow manufacturers to invest in production capacity with confidence. It may also 
improve the accuracy of periodic forecasts by consistently using the appropriate model and 
monitoring outcomes to decide whether instances of errors are within specified limits. Several 
internal and external factors influence forecasting efficiency and order planning, indirectly 
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increasing market stability and markup safety (Pirc et al., 2016). Demand forecast error 
adversely affects supply chain performance, low resource usage, obsolete inventory, poor service 
outcomes, and revenue loss. Subsequently, forecasting is a critical tool in supply chain 
management (Simchi-Levi et al., 2008). Errors have a significant effect on the ability to make 
successful business choices. It is essential to use a formula that eliminates all positive and 
negative averages, ratios, and mean deviations as much as possible. 
Hospital Pharmaceutical Supply and Demand Management 
History Supply and Demand in any Market. According to Whelan and Msefer (1996), 
the rate at which a consumer wants to purchase a product is demand. In economics, demand 
includes being able to purchase and taste. Taste in this context is the wanting for a product or 
service. The ability to purchase has to do with the price and the affordability of that price. The 
market price plays a significant part in demand. Demand usually is low when the prices are 
higher, and demand is high when prices are low. Supply is how much of a service or good is 
accessible at each cost. It is the seller that determines the ability to supply goods. More supply 
will be available at higher prices due to maintaining a profit of higher cost manufacturing. 
According to Marshall (1920), supply and demand are essential topics in economics. Delivery 
and demand determine the quantities sold in every market and the price creation.  
A principle was established by Marshall (1920) on the general law of demand, stating 
that the quantity demanded increases with a fall in the price. Smith (1863) noted that a decline in 
a commodity's price allows suppliers to decrease quantities before the cost of that commodity 
approaches its natural level. An essential part of supply chain management is demand 
management. Demand management is the process that equalizes the customer’s need with the 
abilities of the supply chain. An adequate system, supply can be matched with the demand to 
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implement a plan with minor interruptions. Croxton et al. (2002) argued that a sound operating 
system and good forecasting are insufficient and that "demand management should include 
finding ways to reduce the adaptability of demand and increase operational flexibility and 
implement a good contingency management system so that the organization can respond quickly 
to unintended issues" (p. 64). 
Role of Supply and Demand in Hospital Pharmaceuticals Shortages. A drug shortage 
is a deficiency in delivering a medicinal product, which affects the patient's ability to access the 
necessary treatment in due time. The origins of drug shortages are complex and varied, and the 
problem can be both on the supply side and on the demand side (Pauwels et al., 2015). Problems 
of supply and demand occur when demand for drugs increases beyond expectations or capacity 
of production. For instance, pharmaceutical prices' awareness does not significantly change 
because these medically essential pharmaceuticals have few alternatives and are mostly acquired 
through health insurance by consumers with pre-established rates (Thomas, 2012). Rachmania 
and Basri (2013) claimed demand forecasting is vastly needed to develop an applicable inventory 
control. Precise demand for pharmaceuticals can be a tough challenge. One of the issues with 
this situation is not getting the right documentation for drug usage.  
Furthermore, the brand choice of various drugs from doctors allows certain drawbacks 
for market forecasting. To incorporate this, some analysis of demand should be possible directly 
from the bat, then the numerical modeling for accuracy should be seen, and these examples re-
enacted. In a hospital, the way of supplying pharmaceuticals to patients is through the supply 
chain of pharmaceuticals. The cost of pharmaceuticals is continually rising. Berdan et al. (2019) 
remarked that generic drugs are a common reason for drug shortages.  
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There are not many companies that can manufacture low-margin items. The 
unpredictable consumer demand cannot survive with such a small supply due to suppliers' lack 
of generic drugs. Mensah et al. (2015) stated that hospitals worldwide seek ways to reduce costs 
and improve efficiency without compromising the care and services to patients. "Assessing the 
supply chain process leads to the identification of problems and opportunities. Having a strategy 
and measuring key parts are necessary to understand and take control of the supply chain" 
(Mensah et al., 2015, p. 153). The relationship from consumer to the supplier is a complex 
supply network. The system is complex because pharmaceutical requirements for healthcare are 
numerous. "Pharmacies are the final step in the pharmaceutical supply chain before the products 
hit the customer" (Kaiser, 2005). According to Kaiser (2005) the cycles of hospital 
pharmaceuticals include:  
• Manufacturing sites produce pharmaceuticals. 
• Pharmaceuticals transferred to wholesale distributors. 
• Pharmaceuticals stocked at retail, mail-order, and other types of pharmacies. 
• Pharmaceuticals are subject to price negotiations and processed through quality and 
utilization management screens by pharmacy benefit management companies (PBMs). 
• Pharmaceuticals delivered to and taken by patients.  
In logistics and supply change management, demand forecasting is the core of organizational 
decisions. Demand forecasting is the beginning of planning and executing the supply chain. The 
notion that pharmaceuticals are a strong industry for the supply chain, there is a lack of supply 
chain technology that may improve efficiency and the quality of patient care.  
The complexity of pharmaceutical products can hinder effectiveness and performance 
improvement in the supply chain. The complexity comes from a limited and highly regulated 
45 
 
supply and delivery (Merkuryeva et al., 2019). Eventually, supply chain problems affect the 
supply of drugs based on the decisions made by end-users. Wholesalers or hospitals may have 
bad purchasing practices, delays in production, restrictive distribution methods, and stock 
approach focused on increased cash flow contributing to drug shortages (Tyler & Mark, 2002. 
Because of the current trend in the use of health facilities, demand forecasting predicts how 
much of the products and services will are required at a specific time. The prediction would 
suggest the facility balancing product use holds the developer of the baseline with the holding 
stock's value. Since demand forecasting relates to historical knowledge, there is often some 
uncertainty about forecasts and inventory rates that require adjustments to enable future 
uncertainty about demand (Ignaciuk, 2014). 
Forecasting and Supply Chain Management 
Forecasting. Forecasting acts as decision support tools that allow leaders to plan for the 
future by undertaking "what - if" analyses to evaluate how input changes affect results. 
Forecasting is a process that aids inventory decision making to anticipate future demand from 
archival data is demand planning. A considerable amount of these is subject to volatile demand 
in a warehouse of hundreds of items (Ellram & Cooper, 2014). Forecasting accuracy is one of the 
leading performance indicators measuring many organizations' functions focused on improving 
supply chain efficiency. The main aim of most supply chain-managing operations is to balance 
supply with demand. Demand forecasting is the point of departure for all attempts to achieve this 
objective (Ki-Seok, 2015). According to Spithourakis et al. (2011), supply chain management 
professionals must use a range of up-to-date resources to make educated and effective decisions. 
An organization will be able to predict future trends that can make the market work in their 
favor, through reliable historical evidence or expert opinions.  
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There are many plans in the service industries such as the hospitals that rely on the 
forecast, from capacity planning to aggregate planning, from layout decisions to the supply chain 
management (Kasapoglu, 2016). Although it can be challenging to deliver help products to 
people in need, long-term programs offer an incentive for market modeling supported by 
forecasting techniques. For all healthcare organizations, forecasting demand for health services is 
a significant step in strategic decision-making. This job, which financial managers frequently 
take on, involves first of all the collection and review of historical records (Cote & Tucker, 
2001). Health forecasting is a new forecasting field and a powerful resource for anticipating 
potential health incidents or conditions such as health service demands and healthcare needs. 
Health forecasting promotes plans for preventive medicine and health care initiatives by pre-
informing health service providers to take effective mitigation steps to reduce risks and meet 
demand. Health forecasting requires accurate data, information, and analytical tools to predict 
particular conditions or circumstances in health. 
Forecasting Methods. Service demand forecasting is the first important step in 
determining the future course of a healthcare organization. As such, healthcare companies need 
the best possible demand forecasts for their services.  
There are several approaches to demand to forecast. Whatever approach used, the 
following issues should be satisfied: 
1. The necessary data should be readily available. Financial records typically represent the 
best source of historical data regarding utilization. The forecasting method should be able 
to use these data. 
2. Existing staff members equipped with readily available tools, such as spreadsheet 
software, should be able to perform the forecasting in-house. 
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3. The forecasting method and its results should be understandable not only to financial 
management staff but also to those who use the results for decision making. (Murray & 
Tucker, 2001) 
A crucial aspect of the forecasting process, in addition to these issues, is understanding 
that forecasts based on historical data constitute only the starting point for demand forecasting. 
Although historical data provide the best outlook for the short term, healthcare managers know 
that demand for healthcare services is complex. Qualitative forecasting is a forecasting approach 
based on intuitive or judgmental assessment. For example, expert opinion and knowledge about 
specific events of the sort already described, which may or may not take the context into account. 
Typically, it is used when data is sparse, inaccessible, or no longer relevant. Quantitative 
forecasting is a forecasting approach where historical demand data projects future demand. 
Extrinsic methods and intrinsic ones are usually used (Spithourakis et al., 2011). Most of the 
traditional demand forecasting focuses on mathematically extrapolating past demand into the 
future on the premise that future demand followed the same statistical patterns as in the past 
(Lawless, 2015). A few of the most common forecasting approaches are discussed in this study. 
Judgment Forecasting. The collection of professional opinion is the Judgement 
forecasting method. Judgment forecasting combines expert information with statistical 
forecasting, including whether expert expertise will enhance the accuracy of forecasts. Human 
judgment can offer a significant advantage to forecasting accuracy, but this may also be subject 
to various biases (Lawrence et al., 2006). Judgmental forecasting includes various types of 
predictive judgment, including forecasts based on contextual information, information of 
intervals, or predictive model judgment (Petropoulos et al., 2018). In practice, it is reasonable to 
predict using judgment. In some instances, judgmental forecasting is the only choice, for 
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example, when a complete lack of historical data, when a new product is launched, or when a 
new competitor enters the market, or under entirely new and unusual market conditions. 
Judgment must be applied to forecast such a program's effect because there are no historical 
precedents (Goodwin & Wright, 2009). 
Delphi Method. The pharmaceutical industry plays a significant role in supplying drugs 
and saving human lives. In this sense, any risk affecting the pharmaceutical supply chain may 
affect health system efficiency and interrupt the supply of medicines (Tazin, 2016). The Delphi 
method is a method of forecasting in which a select number of experts merge market orientation 
and assessments using an iteration function. It is an instrumental technique for evaluating data in 
which experts express their views, expertise, and experience before mutual consensus is reached 
(Chuang et al., 2013). With the Delphi method, the most critical threats in pharmaceutical supply 
chains are finalized. There is no particular restriction to considering data evaluation by experts 
(Markmann et al., 2013). The outcomes of these iterated variations help to establish the next 
parallel meeting points for a particular prediction to be sought. This approach has been proved 
successful and accurate for long-term forecasts (Markmann et al., 2013). 
Focus Groups. The focus groups are a popular form of qualitative forecasting (Simchi-
Levi et al., 2008). It involves engaging in an open-ended dialogue involving five to ten people 
from a company's target customers. There is typically a moderator who seeks turn-taking among 
the participants and often asks questions about their products, brand awareness, and related 
concepts. Participants are supposed to provide insightful responses that reflect the perspective of 
a wider audience they are targeting. Discussions in focus groups can involve rewards such as a 
financial reward or some similar measure in terms of free goods. Current forecasting methods 
restrict the context of the market available (Blackburn et al., 2015). 
49 
 
Time – Series Methods. A time series is ordered in time by a sequence of data points. 
Time is always the independent variable in a time sequence, and the goal is generally to predict 
the future and order series of observations at equally spaced time intervals of a variable or 
captured object. Time series is measured at regular intervals sequentially over time, such as 
hourly, daily, weekly, monthly, and quarterly. Time series information is essential when 
forecasting something that will change over time using past data. In the analysis of time series, 
the aim is to estimate the future value using past data behaviors. This second concept's 
significance in terms of health forecasting is the focus it puts on the "uniformly spaced time 
intervals," which is important in the use of health data for health forecasting.  
Time series thus provides a statistical framework for analyzing seemingly random 
fluctuating health data and the potential prediction of the data series (Chatfield, 2004). The trend 
is the long-term variability in the data in a time series not influenced by unusual or seasonally-
based components. For example, a cumulative record of a gradually increasing occurrence over a 
given duration of health data will indicate a growing pattern, regardless of any random or 
systemic fluctuation (Chatfield, 2004). There are several widely used methods, each with varying 
benefits and drawbacks (Simchi-Levi et al., 2008). Common time-series methods include: 
Exponential Smoothing Model. A widespread forecasting method within supply chain 
models is the exponential smoothing method. The use of a particular forecasting method affects 
the costs of a supply chain. For hospital drug expenditures, exponential smoothing forecasts a 
projected value for the preceding time based on the prediction, adjusting the prediction error. 
New data are weighted more heavily than older data; weights decrease as data get older (D'Sa et 
al., 1994). 
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Moving Average. Simply this method says the next observation is the mean of all past 
observations. The aim here is to pick the number of points on the moving average to minimize 
the impact of data irregularities (Simchi-Levi et al., 2008).  
Casual Method. Causal forecasting is the methodology that assumes a cause-effect 
relationship between the variable to be forecast and one or more other independent variables. 
Causal strategies typically take into account all possible variables which can influence the 
dependent variable. Therefore, the data needed for such forecasting can vary from the internal 
sales data to external data such as surveys, product features, and social chatter. Causal models 
are typically continuously updated to ensure the latest information is integrated into the model 
(Anandhi et al., 2012). 
Predictive Analytics and Big Data 
 Relationship of “Big Data” in Healthcare. In recent years, there has been a growing 
interest in developing demand forecasting systems for supply chains to help predict, advise 
orders, allocate resources, and help meet demand (Shafique et al., 2019). The four technological 
characteristics of big data are veracity, variety, volume, and velocity. These four properties 
present their information challenges, according to (Rajaraman, 2016). Veracity is the degree to 
which reliable and precise data is trusted. Volume is datasets that are too large to be controlled 
by traditional tools and systems. Variety is datasets that are both formatted structured or 
unstructured. Velocity is datasets that have data to be analyzed quickly because of data that is 
time sensitive. Hospitals that develop their warehousing system for data can integrate the four 
properties and all of the other data systems into one database with a common format. The 
processing and management of massive data sets is a challenging task in and of itself, but one 
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that is important for the development of descriptive and predictive analytics applications 
(Alharthi, 2018). 
Organizations can obtain data-driven insights in data analytics by finding trends in 
historical data, such as changes in the sales of various products and preferences for consumer 
purchases. For example, businesses can use simple techniques such as drawing charts to find 
patterns in the data, use regression to understand the relationship between different variables, or 
view data to improve data (Pyne et al., 2016). Such descriptive insight will improve the ability of 
an organization to develop new products or expand current product lines properly. To order to 
predict future events and patterns, organizations can also combine massive amounts of data from 
different sources (Ghasemaghaei & Calic, 2019). This predictive ability allows businesses to 
forecast their market patterns and overall performance, which can lead to new product 
production or existing product improvements.  
Online retailers, for instance, can use customer online behavior, customer purchasing 
history, such as page views, time spent on each page to gain predictive insight by predicting 
consumer behavior while developing new goods. Knowing the best course of action and gaining 
prescriptive knowledge allows companies to refine their processes of discovery or exploitation. 
For example, companies can use simulations to analyze various scenarios and find optimal 
solutions in the processing of current products. As a result, businesses that effectively produce 
market insights will boost their innovation skills (Pyne et al., 2016). 
Another example of an emerging technology designed to handle extensive data with 
significant implications for healthcare environments is data analytics. Such instruments examine 
patterns for gaining knowledge and insights in vast and complicated datasets. The use of data is a 
crucial tool for health organizations to deliver better healthcare services and cut costs. Just like 
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other industries, healthcare analytics can be predictive, descriptive, or both (Alharthi, 2018). 
Because of analyzing current and historical data in predictive analytics, the results may identify 
signatures or detailed patterns of clinical weakening before it becomes apparent, which makes 
the case of being proactive instead of reactive in medicine (Michard & Teboul, 2019). Using data 
from healthcare, while focusing on predictive analytics, is developing as a transformative 
instrument that will allow more treatment options that are preventative and proactive (Alharthi, 
2018). A large variety of clinical systems and population delivery interventions can be simulated 
by predictive analytics to predict outcome measures and forecasts from scenarios of health 
intervention delivery. Such initiatives are part of major movements that seek to understand how 
best to balance areas such as accuracy in medicine, accuracy in public health, and community 
health (Dolley, 2018). 
 History of Predictive Analytics. Predictive analytics is a general approach used to solve 
a variety of business needs, problems, and concerns. Predictive analytics is the method of 
extracting data from current data sets to determine patterns and forecast future trends and 
outcomes. Predictive analytics is not asking you what is going to happen next. It predicts with an 
appropriate degree of precision what might happen in the future and provides what-if scenarios 
and risk assessment (Lawless, 2015). Shmueli and Koppius (2011) stated for assessing predictive 
power, predictive analytics uses statistics and other empirical methods to generate information 
predictions. The techniques of predictive analytics also include business intelligence, artificial 
intelligence, and learning of deep algorithms (Alharthi, 2018). Finlay (2014) stated the center of 
predictive analysis depends on the capture and exploitation of relationships between explanatory 
variables and predicted variables from past events to predict the unknown outcome.  
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It is imperative to note, in any case, that the precision and ease of use of results will 
depend significantly on the degree of information investigation and the nature of assumptions. 
The industries that use predictive analytics include finance, marketing, healthcare, and 
pharmaceutical research. Using predictive analytics could increase the provider's and researcher's 
access to high-quality patient data. (Fan et al., 2014). What differentiates predictive analytics 
from forecasting is that predictive analytics is at a level of granularity that is more detailed. 
Predictive analytics uses probabilities for each separate organizational component. Learning 
from prior experience to predict a future pattern will aid in better business decisions (Siegel, 
2013). Although most organizations generally use big data in warehouse optimization, some 
organizations are starting to use predictive analytics to make more informed decisions by using 
insight into the data. In healthcare, searching through large amounts of data and analyzing data to 
predict outcomes is predictive analytics for individual patients. The data included in predictive 
analytics can come from published journals, databases, and past treatment outcomes of patients. 
Big data and predictive analytics have significant potential to support more reliable, more 
effective treatment, and recent developments have been noteworthy, especially in the field of 
image analysis (Voets et al., 2019). 
 Predictive Analytical Models. According to Alharthi (2018), healthcare organizations 
have started to execute predictive analytics to process and manage big data to discover trends, 
predictions, and hidden relationships that support improved healthcare services delivery. 
Kankanhalli et al. (2016) claimed global healthcare systems face increasing pressure from the 
maturing population and lifestyle changes. Along with the groundbreaking advancements in 
digitized patient and wellness data, primary and secondary data are growing. While the mass of 
information offers open doors for enhancing healthcare delivery, policymaking, and 
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management, new technology frameworks and methodologies will hopefully leverage the vast 
data. According to Gim et al. (2018), business-related data analysis can be divided into three 
categories: 
1. Descriptive analytics: a collection of technologies and processes for understanding and 
analyzing business results using data. Descriptive statistics are an integral part of 
biometric research, and a prerequisite for understanding more statistical assessments, 
including inferences drawing. When data are well presented, it is generally evident that 
the author has obtained and interpreted the data accurately and in compliance with agreed 
field practice (Spriestersbach et al., 2009). 
2. Predictive analytics: predicting outcomes using several analytical and computational 
approaches based on data input. This approach examined many predictive relationships 
and proposes a framework to optimize business performance. Although relatively new, 
real-time reporting can deliver timely insights into information and can be used to 
vigorously adjust the predictive algorithms in line with new ideas and discoveries. 
Predictive analytics utilizes information from its wellbeing data framework to recognize 
patterns and examples in drug use in the perioperative setting and create methodologies 
to repackage mass meds into littler unit dosages at whatever point conceivable. The 
approach helps the hospital to stock up on supply, decrease squandering, and extend hard 
accessibility to get medications and shortages (Fan et al., 2014). 
3. Prescriptive analytics: A collection of computational methods for evaluating complex 
business results goals, criteria, and limitations. This approach describes different 
alternatives and recommendations based on results from descriptive analytics and 
predictive analytics. Prescriptive analytics seeks to recommend (prescribe) the best 
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decision choices to take advantage of the predicted future by using vast volumes of data 
(Pedersen et al., 2018). Prescriptive analytics has two types of human intervention: 
support for decision making (e.g., offering recommendations, automation of decision 
making, executing the prescribed action; Lepenioti et al., 2020). The usefulness of the 
prescriptions varies on how well these models combine a blend of unstructured and 
structured data, reflect the domain under review and capture the impacts of the analyzed 
decisions (Pedersen et al., 2018). 
Machine Learning. Machine learning refers to algorithms that rely on models and data 
processing based inferences without using explicit instructions. Machine learning includes basic 
knowledge, which we see in a graph. Machine learning algorithms create a mathematical model 
of sample data, known as "training data," such that predictions or decisions can be made without 
specific programming for the task (Bishop, 2006). 
Recommendations for Improving the Costs of Hospital Pharmaceutical Shortages and 
Improve Efficiency 
 When executing initiatives that will impact drug expenditures in a hospital system, it is 
critical to have a method for prioritizing and planning particular pharmaceutical cost 
management strategies (American Journal of Health-System Pharmacy, 2008). Iyengar et al. 
(2016) detailed there are single or multiple reasons for drug shortages, extending from “problems 
at the production level to weak supply chains that prevent medicines from reaching points of 
care” (p. 1). No matter what the reason, drug shortages increase hospital pharmaceutical costs. 
According to Pace et al. (2015), pharmacotherapies play a vital role in the treatment of diseases, 
although expensive. One of the hospital’s highest expense centers in the pharmaceutical division.  
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In recent years, the medical costs per capita for ambulatory and hospital patients have 
increased due to variables that decision-makers are not easily manipulating, such as the 
increase of life expectancy, the growing population, and the emergence of new diseases, 
among others. (Franco, 2020, p. 1)  
New standards and quality requirements allow pharmacies to have more services to ensure that 
adequate measures are placed in place to improve patient safety and well-being to the highest 
level. Simultaneously, the pharmacy speaks to a prime territory of the center for improving cost 
efficiencies and benchmarks for reimbursement. Going ahead, hospital pharmacies should 
improve operational procedures to make sure employees use their time wisely (Pace et al., 2015). 
There is a significant impact on hospital inventory spending due to drug shortages. 
According to Gu et al. (2011), there is an increase in government regulations to improve 
correspondence on the many factors that lead to drug shortages. Discussing alternative options 
can lead to cost savings strategies, quality improvement programs, and opportunities to enhance 
clinical practice when a product suddenly becomes unavailable (Clark et al., 2019). McKesson 
(2019) stated that because of the negative effect on patient care and financial burdens, drug 
shortages may create; an organization should have a prepared response in the event a drug 
shortage occurs. Having resolved the shortage situation, the organization should resume standard 
operating procurement procedures. There must be a dedicated pharmacy staff member dealing 
with drug shortages, given the number of shortages that occur. Some hospitals reported that three 
FTE pharmacy staff were primarily involved in drug shortages management. To do that, most 
hospitals do not have the money or personnel. Identifying the problem is not the only thing that 
is labor-intensive. A drug shortage management system requires time and effort, as well as 
measures to assess and execute in response to the shortage (McKesson, 2019). 
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A case study on challenges hospitals face because of drug shortages suggests that hospital 
pharmacies should be proactive. Hospitals need to pay attention to the signs that a drug shortage 
is pending. When organizations such as the ASHP and FDA release information of partial fills 
and unavailability, contact should be made with the producers of the drugs to see how long the 
shortage will last and if there are any alternatives (Rich, 2013). Communication is crucial to 
diverse lists of medication availability as all parties need to be aware of issues, ranging from 
distributors, pharmacists, nurses, procurement managers, drug safety officers, and pharmacy 
informatics. A proven drug shortage guideline or policy allows hospitals to respond timely and 
efficiently to real or probable drug shortages, guaranteeing high-quality clinical care for patients, 
and reducing the risk of adverse effects and poor results. Written updates, electronic medical 
record warnings, and correspondence via e-mail are options for transmitting information through 
health systems (McKesson, 2019). 
In the case of COVID-19, there is a shortage of hard information; worries about depleting 
(or idling) stock are increasing, and companies worry that contractual obligations will not be 
fulfilled. Understanding how global companies are managing their supply chains through 
disruptions will help all businesses coordinate their responses (Sanders, 2020). Keegan (2020) 
impacts in many sectors seem inevitable in many religions. Chinese supply costs will rise sooner 
than later, stemming from overtime and expedited freight costs, as well as paying premiums for 
buying up supply and maintaining power (Keegan, 2020). Companies also operate through 
alternate procurement approaches such as; implementing a program for tracking supply rates, 
including protection to prevent theft or store limited protective gear, including N95 masks and 
personal protective equipment. Identifying alternate supply possibilities and deciding what they 
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mean for operations will be crucial — for instance, when cases of viral transmission occur in 
various regions (Sanders, 2020). 
Benefits of Using Predictive Analytics for Hospital Pharmaceutical Shortages. In 
recent years, pharmaceutical shortages issues have been growing globally. There are various 
definitions of drug shortages that include supply issues, how drugs are prepared and dispensed, 
lack of supply for patient demand, and manufacturing issues. Regardless of what the definition 
is, the bottom line is that a shortage in hospital pharmaceuticals will negatively affect patient 
care (Holcombe et al., 2018). Big data predictive analytics is a reliable tool in supply chain 
management. Big data predictive analytics will help with the relationships between suppliers and 
buyers to boost the efficiency and performance of the supply chain (Shafique et al., 2019). For 
the pharmaceutical industry, it is wise to use big data to predict the future. According to 
Hernandez and Zang (2017), the term big data is viewed in healthcare as large quantities of 
health records that are electronic, data from clinical trials, administrative claims, phone 
applications and social media. Hernandez and Zang further claimed that broad data used in 
predictive analytics may help complicated patients and patients at high-risk drug risks in various 
areas of prescription management. Shafique et al. (2019) claimed within big data technology, big 
data predictive analytics can be defined as the systematic method used to collect, store, organize, 
use, transfer, and visualize data to predict future trends. Hence, through the conception of big 
data referred to as big data predictive analytics, hospital pharmaceutical shortages can progress 
the performance of their supply chain (Duan & Xiong, 2015).  
According to Admes and Garets (2014), predictive analytics may use a specific set of 
data to make predictions based on historical events or modeling. There are many and significant 
clinical applications of predictive analytics, as personalized patient result predictions are 
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feasible. For this reason, there has been a great deal of interest in predictive analytics in 
healthcare settings as of late. The knowledge gained by applying predictive analytics to 
healthcare would change the practice of medicine while enhancing the ability to treat and prevent 
major diseases and diseases. The role of predictive analytics will expand in drug optimization as 
better predictive tools, and more patient data becomes available. Establishing a regularly meeting 
drug shortage committee has allowed an active approach to handling all facets of drug shortage 
management in planning for future events (Clark et al., 2019). Using predictive analytics can 
increase the quality of hospital operations. In short, forecasting is a method that looks at numeral 
data from a time series and forecasts the future value for the information that looks at the 
patterns. In contrast, a predictive analytical model takes in a variety of variables and forecasts 
future behavior where numbers may or may not be all of the data points. 
Literature-Based Potential Themes and Perceptions 
The literature review of this study examined the rising cost of hospital pharmaceutical 
shortages and the impact on patient care. The researcher identified and explored manufacturing 
problems as one of the reasons for rising hospital costs of pharmaceutical shortages.  
Supply Chain Management and Healthcare. According to Min et al. (2019), supply 
chain management includes planning and managing all procurement activities, adaptation, and 
all activities of logistics management. The supply chain also involves cooperation and 
communication with channel partners, which may include distributors, intermediaries, third-party 
service providers, and consumers. Supply chain management fundamentally combines the 
management of supply and demand within and through businesses. Supply chains in hospitals are 
unique and, in many ways, different from the conventional industrial supply chains. It is a 
dynamic system that requires the distribution of products and services to meet the needs of 
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patients (Mathur et al., 2018). Over the past few decades, the healthcare sector has been facing 
continually rising price challenges. There will be a decrease in profits and market share if there is 
a lack of supply chain management efficiency (Ellram & Cooper, 2014).  
Experts and practitioners have increasingly focused on different supply chain approach 
for Supply Chain Management (SCM) to cope with ongoing changes in their design, meaning, 
and requirements (Banomyong & Supatn, 2011). More organizations are incorporating 
technology into their supply chain management systems to remain globally competitive. 
Consumers have become increasingly demanding in recent years, setting high expectations in 
terms of quality and service. Simultaneously, supply chain managers realize that the latest 
technology can help them to ensure better liability and visibility, permitting them to stay ahead 
of the pack and keep tight control (Scholten & Schilder, 2015). Problems of supply and demand 
arise when demand for drugs rises beyond expectations or the ability of production. Supply chain 
activities allow the healthcare system to efficiently monitor and actively track the desired goals 
as an invaluable management tool and mechanism to achieve success. Successful SCM may 
result in a reduction in the overall amount of resources needed to provide the required level of 
customer service and enhance customer service through increased availability and reduced or 
decreased product availability (Reefke & Sundaram, 2016). 
Hospital Inventory Management Challenges. Yildiz and Khan (2018) reported that the 
administration of inventory management is a part of the business the board that explicitly centers 
on arranging and overseeing inventories. While public hospitals are not business units, to 
improve their customer orientation, inventory management is also essential for public hospitals. 
The general accounting principle considers inventories as "'capital' or 'asset' that will, in the 
future, convert into service or product sales” (p. 500). A problem for operating systems was the 
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design of a reliable inventory management mechanism under volatile conditions of demand 
(Ignaciuk, 2014). The surplus or deficit of each item shall determine the basis of the effects of 
the forecasts in the inventory control process. According to Wang et al. (2015), hospital 
inventory management, however, is more troublesome than modern industrial systems, as the 
majority of medical and surgical inventory must be of sufficient quantity and quality for the 
workers to use at all times. Over the past few years, the need to address barriers to efficient 
supply chain inventory management has become more critical for hospitals and health systems as 
they face cost-cutting pressures while improving patient outcomes under the Affordable Care Act 
(Beamesderfer & Ranji, 2012). Automation, analytics, and interfacing will assist health care 
providers in improving inventory management while reducing costs and encouraging better care. 
Hospitals can reduce supply chain costs without sacrificing quality by implementing more active 
inventory management systems (Wang et al., 2015). 
Challenge of Pharmaceutical Shortages. Gu et al. (2011) reported that drug shortages 
were first overserved in the United States, where drug treatment is more customary than 
anywhere else in the world. Conversing and seeking practical solutions to the problem of drug 
shortages is vital because scarce drugs are necessary for the treatment of most critical health 
conditions, and shortages in any of them inevitably disruptions in patient safety and quality of 
healthcare. Due to the various factors leading to drug shortages, more government regulations 
are implementing improved communication between the multiple parties involved (Thomas, 
2012). Problems with manufacturing are just one of the reasons that cause drug shortages, mainly 
because of quality, materials, and even factory closures, according to the FDA (Gu et al., 2011). 
"Some of the unpredictable factors include natural disasters, raw materials, non-compliance with 
regulatory standards, and voluntary recalls" (Ventola, 2011, p. 748).  
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Natural disasters, such as earthquakes, fires, and hurricanes, have an impact on the supply 
of pharmaceutical products in the following ways. For example, finished goods are destroyed, 
and the loss of sites leads to long-term shortages in cases where there is only one manufacturer. 
(Tyler & Mark, 2002). Moreover, a product may depend exclusively on one primary raw 
material, which can only be manufactured by a manufacturer of a sole source. Dill and Ahn 
(2014) reported that a lack of access to vital medicines should not be a common problem in any 
country; however, drug shortages have become a primary global concern. Lack of access to 
critical medication should not be a common problem in any country; however, drug shortages 
have become a major global concern. Additionally, prompt notice from a supplier of a possible 
or imminent drug supply disruption is highly related to the ability to alleviate and avoid a drug 
shortage in any developed country or regulatory agency under any circumstances. This early 
warning in the US has greatly increased the ability of the FDA to respond more rapidly and more 
efficiently to emergencies, as it allows for a more accurate and efficient response (Dill & Ahn, 
2014).  
Impact of Pharmaceutical Shortages. Effective drug shortage management presents 
significant challenges. Drug shortages affect every health care system stakeholder, and there is a 
need for concerted efforts to address and reduce shortages. Drug shortages are likely to affect the 
workload and medical decision-making and have a clinical and financial impact (Pauwels et al., 
2015). Health care institutions regularly require quick access to specific medicines to treat 
patients with acute and emerging conditions. Drug shortages have a clear impact on public health 
and patient outcomes. Shortages may result in missed doses, prescribing inaccuracies, errors in 
dispensing and administration, decreased compliance of patients, and increased health care costs 
(Balkhi et al., 2013). Difficulties in manufacturing, supply and demand, industry and economy, 
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legislation, supply chain, and health care systems all impact drug shortages. When a company 
transfers its money from manufacturing to analysis or the development of an alternative product, 
this contributes to production losses, which can lead to redundancies (Gu et al., 2011).  
Furthermore, substitute medical treatments may also have different side effects or maybe 
less effective than initially prescribed (Balkhi et al., 2013). Prescribing alternative medicines can 
lead to errors in medication, such as incorrect dosage. Many patients may need medication as a 
matter of urgency, but drug supply shortages will lead to the rationing of most critical patients. 
The issue with medication shortages is the regulation of performance. Substitute drugs may not 
live up to the required quality when there is a shortage of drug supply. Hospitals or hospitals may 
need to buy drugs from less reliable outlets (Thomas, 2012). It is critical to have a plan in place 
before shortages arise. To determine the cause of the shortage and the expected time and period, 
the pharmacy team will contact drug suppliers, the FDA, and the CDC. Prioritization of patients 
may be appropriate, and organizations such as CDC may provide clinical guidelines. 
Additionally, the hospital pharmaceutical interdisciplinary group should also develop a patient 
prioritization plan using an evidence-based approach that provides recommendations for clinical 
practice and original research (Fox & McLaughlin, 2018). 
Data, Analytics, and Healthcare. Fadiya et al. (2014) stated that a considerable amount 
of data had invaded the planet. Due to digitization, the adoption of information technology as a 
useful tool, and the Internet becoming a compelling user interface for daily exchanges, all 
industries, and all their activities are involved. Nevertheless, in terms of volume, variety, and 
velocity, these generated data are becoming increasingly difficult to manage. A new big data 
field was born (Gandomi & Haider, 2015). Many analytical programs can improve the future 
outcomes of models that employ art and science. The data used for such a model are the existing 
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data from multiple resources. The way researchers and practitioners handle, analyze, and exploit 
data in any field has changed with Big Data. Voets et al. (2019) said that healthcare is one of the 
most critical areas for reform. Healthcare analytics may reduce treatment costs, predict 
contamination episodes, preventable infections, and improve the overall quality of life. 
According to Huang et al. (2015), big data analytics application in healthcare has many 
empowering and life-sparing. Big data information alludes to the considerable measure of data 
created by digitizing all that is put away and handled by explicit advancements. Applied to 
healthcare, it will utilize precise wellbeing information from a populace (or individual) and may 
help prevent epidemics, cure disease, and reduce costs. Huang et al. (2015) also argued that this 
medical data revolution has the ability at the point of care to change patient decisions. 
Complicated creative and high price-specific drugs are increasingly entering the health care 
market. This trending translates from providing care in health facilities that are now 
implementing new modes of safe delivery and improving data analysis. Physicians will be able 
to abstract pertinent information for each patient, which will give better choices and results.  
Predictive analytics has the ability to boost the company's demand predictions and 
production plans significantly. It can evolve with changing conditions and consumer needs and 
behavior. It will help the company better understand what drives both positive and negative 
demand, thereby giving the company an opportunity for management action and better decision-
making (Lawless, 2015). Traditional demand forecasting is somewhat restricted in its approaches 
and inputs, utilizing a single hierarchy and a single best-fit model to forecast the product at hand. 
At the same time, predictive analytics uses a variety of models and techniques (including 
machine learning algorithms) to analyze broader data sets with many additional properties. It 
may even involve infinite quantities of simple variables. Since predictive analytics can predict 
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various outcomes, pharmacists can have a greater understanding of the threats that each patient 
faces from particular medication-related issues (Hernandez & Zhang, 2017). Through employing 
Predictive Analytics as a decision-making and forecasting method within the organization, the 
business and all its stakeholders will have a significant economic benefit (Lawless, 2015). 
The field of healthcare can benefit from predictive analytics, mainly when large sets of 
independent and weighty data exist. Providers, along with pharmaceutical and medical device 
manufacturers, tend to look for ways to improve medical outcomes as health care services 
progress. Through organizing and directing medical decision-making, predictive analytics can 
help to reduce and control costs and improve clinical trials that can influence future research 
(Raghupathi & Raghupathi, 2014).  
Summary of the Literature Review 
The literature review's goal was to analyze the existing literature to determine the case for 
the research methodology that the study examined. The analysis of existing literature helps the 
reader understand the overall business problem of the rising costs of hospital pharmaceuticals 
and the impact on patient care. The literature review is divided into five sub-sections, a brief 
history of the United States healthcare system, an overview of supply chain management, 
healthcare industry issues, supply and demand for hospital pharmaceuticals, and the possibility 
of predictive analytics and supply chain management as a potential solution to the business 
problem. The literature concluded with a discussion of the researcher's initial literature-based 
perceptions and themes. 
Transition and Summary of Section 1 
The first section of the study consisted of the problem under examination, the purpose of 
the study, and the research questions to be explored to make a convincing case. The research 
66 
 
study's framework includes analyzing what the study involves and why it is useful. Background 
information has been provided in this section to help in understanding the need for the study. 
Then, the statement about the problem and the study intent was clarified. The review's intent was 
discussed on the nature of the study, describing the research and design method chosen for the 
study, as well as explaining why the other methods and designs were not selected.  
The next part of Section 1 included the research questions and the conceptual structure to 
be used in the study. The conceptual framework consists of a narrative and sometimes a visual 
structure that represents the logical connections between key elements of interest in philosophy, 
structures, and phenomena. The significance of this research relating to the cost of 
pharmaceutical shortages in hospitals, and the effect on patient care, Biblical Implications, the 
connection to the strategic management, and key terms were defined. Furthermore, assumptions, 
limitations, and delimitations were acknowledged as to specify the broad scope of the research. 
The first section concluded with an exhaustive review of existing literature relating to the focus 
of this study. The next section of this study will describe the research method and design. The 
purpose statement will be reintroduced, along with the role of the researcher and the participants. 
Furthermore, the process and design of the study, population sampling, data collection, and data 
analysis will be discussed. Finally, the second section will conclude with the technique, 
reliability, and validity of the study. 
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Section 2: The Project 
This research study explored the rising costs of hospital pharmaceutical shortages and the 
impact on patient care: exploring the use of predictive analytics in New York area hospitals. 
According to Berdan et al. (2019), pharmaceutical shortages represent a significant problem for 
hospitals. One hundred and twenty-one (101) primary lifesaving drugs are in short supply today, 
and at least 50 shortages a year are recorded by 70 percent of all hospital pharmacists. Providers 
may have to postpone medically necessary treatment or alternative treatments that may not be as 
effective without these lifesaving medications at hand (statnews.com, 2019).  
The qualitative research method and case study design are determined the best fit for this 
study to expand on existing research and answer the research questions. The second section 
begins with the purpose of the study. It then identifies the role of the researcher and the 
participants. The population consisted of New York hospitals, and the sampling was pharmacists, 
pharmacy technicians, and other staff that have experience with hospital pharmaceutical 
shortages. Although a qualitative study, the hypothesis discusses predictive analytics as a 
possible mitigation method for hospital pharmaceutical shortages and the impact on patient care. 
The data will come from interviews based on the participant's experience. Finally, data analysis, 
along with reliability and validity, concludes the second section of the project.  
Purpose Statement 
The purpose of this qualitative case study was to add to the body of knowledge by 
expanding on the understanding of factors driving the rising cost of hospital pharmaceutical 
shortages relating to manufacturing problems and the impact on patient care. The integration and 
coordination of the hospital pharmaceutical supply chain are essential to support patients' care 
(Sweeney, 2011a). Hospital supply chain management has many issues, including increased 
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supplies, manufacturing problems, logistics, and distribution issues. When the supply chain is 
managed effectively, it can positively affect the hospital's bottom line (de Vries & Huijsman, 
2011). Pharmaceutical supply chain management's critical objectives should improve the 
fulfillment of demand efficiently, drive extraordinary client value, build system resiliency, and 
promote financial success (Gibson et al., 2005). The more significant problem was explored by 
studying the rising cost of hospital pharmaceutical shortages, associated with manufacturing 
problems, the impact on patient care, and exploring the use of predictive analytics in New York 
area hospitals.  
Predictive analytics is a concept describing the use of past data to develop informed 
assumptions about future results. Many businesses have been using this sophisticated method to 
assess risk, detect fraud, and the demand for products or services. The study's role in predictive 
analytics was a method for using data to predict and adapt to changing demands based on 
historical events and prevailing trends (Brooks, 2018).  
Role of the Researcher 
The role of a researcher is extensive and detailed. The traits such as ethical, positive, 
adaptive make a researcher qualified to ask relevant questions and reasonably interpret the 
answers while conducting the research (Yin, 2014). In this qualitative study, the role of the 
researcher primarily serves as a facilitator. The researcher will be to identify the best participants 
for the study, contact the participants for the study, administer surveys, and analyze the data from 
the surveys. Dezin and Lincoln (1994) defined qualitative research as being focused on 
multimethod, requiring an analytical, realistic approach to its subject. Sutton and Austin (2015) 
stated that the researcher's role in qualitative research is to try to access the study participants ' 
thoughts and feelings. It is not always straightforward as an encounter can be unique, as the 
69 
 
researcher asks the participants to share their experiences. The researcher is primarily 
responsible for protecting participants and their data. Instruments for such protection must be 
clearly expressed with the participants and approved by the relevant Research Ethics Review 
Board before commencing the research (Sutton & Austin, 2015). 
Participants 
Sargeant (2012) stated that one of the most critical tasks in the design phase of the study 
is to identify suitable participants. Selection decisions are reliant on the research questions, 
theoretical viewpoints, and evidence of the study. Since most qualitative data comes from 
encounters with participants using questionnaires, interviews, focus groups, or surveys, a 
researcher must identify participants who are willing to speak about their experiences. It is, 
therefore, at the core of a planned study to consider a prospective participant who has experience 
with the phenomenon and is willing to share their thoughts (Kuper et al., 2008). In this study, the 
ideal participants would be individuals that have firsthand experience with hospital 
pharmaceutical shortages. Therefore, participants will include pharmacists, physicians, supply 
chain managers, and clinical support staff from New York Hospitals.  
Caulder et al. (2015) suggested that to mitigate the clinical outcome of a pharmaceutical 
shortage, all parties involved must be informed of the impact a shortage will have on the patients. 
“Pharmacists are uniquely qualified by leading initiatives to minimize the impact of drug 
shortages on patient care and benefit health-care organizations” (Caulder et al., 2015, p. 284). 
Next, the researcher obtained approval from the Liberty University International Review Board 
(IRB) and the IRB of the relevant New York Hospitals. After the approval, a consent form and a 
narrative of the study was sent via email to the prospective participants. Details that may have 
identified participants followed the confidential compliance set forth by the IRB. All methods of 
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collecting data, such as notes, transcripts, and recordings, will also be protected following the 
study. 
Research Method and Design 
This study used the qualitative research method and the case study research design. One 
of the critical decisions in qualitative analysis is identifying who or what to include in the 
sample. An awareness drives the sampling method that the qualitative study focuses on 
knowledge building and relevance in line with the specific research question (Kuper et al., 2008). 
Review of case study as a qualitative approach entails far more nuanced than a conventional case 
report, and often creatively incorporates multiple data sources. The case study's depth and 
richness of detail help readers to understand the case and whether results may be relevant beyond 
that context (Alpi & Evans, 2019). 
Discussion of Method  
Qualitative research methods include interviewing strategies, analyzing of documents, 
and observations. The aim is to investigate the attitudes, interaction mechanisms, and the 
meanings, values, and experiences of intentionally sampled individuals and groups in their 
"natural" setting. The desired result is the ability to make conceptual generalizations from a 
qualitative study's local context to other settings (Kitto et al., 2008). Healthcare research, 
particularly clinical medicine, is a progressively difficult field. Evidence-based clinical 
researchers have recently become increasingly aware of the importance of looking at qualitative 
research. Furthermore, a growing interest in exploring the attitudes, values, and experiences of 
those concerned or influenced by health care delivery has brought qualitative research to the 
forefront (Green & Britten, 1998). This study examined the rising costs of hospital 
pharmaceutical shortages and the impact on patient care: exploring the use of predictive analytics 
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in New York area hospitals. The qualitative research method is best suited because it is a 
successful model in a natural setting that allows the researcher to establish a level of detail from 
being heavily involved in the actual experiences (Creswell, 2003). 
In this study, the quantitative method of research was not chosen because the quantitative 
method is based on numerical analysis, science, and the cause and effect of relations (Creswell, 
2014). A deductive methodology is used with quantitative studies in which, preferably, the 
researcher establishes a hypothesis that applies to the subject under study, develops hypotheses 
based on this theory, and then tests such hypotheses with evidence that either supports the 
hypotheses or not (Barczak, 2015). Creswell (2014) stated that when the results need to be 
transmitted mathematically, quantitative analysis is the best research method. Quantitative 
analysis allows organizations to gather statistics on which predictions and plans can be made. A 
study aimed at gaining an insight into the experience with a phenomenon could not be achieved 
using the quantitative method. 
Discussion of Design 
A qualitative case study provides researchers with the resources to analyze complex 
phenomena within their context. After the correct application of the methodology, developing 
theory, reviewing initiatives, and designing strategies become a valuable tool for studies in 
health science (Baxter & Jack, 2008). Yin (2003) identified a case study design should be 
considered when:  
1. The purpose of the research is to address "how" and "why" questions.  
2. The boundaries between the phenomenon and context are not clear. 
3. The actions of those involved in the study cannot be manipulated.  
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4. Contextual conditions should be protected because it is assumed, they are essential to the 
phenomenon being studied.  
According to Stake (1995), case studies are an investigative technique in which the 
researcher investigates a plan, case, operation, procedure, or one or more individuals in detail. 
Cases are confined by operation and time, and researchers gather detailed information over a 
sustained period using a variety of data collection techniques (Stake, 1995). 
Summary of Research Method and Design 
Research design and methods are separate but closely linked because good research 
design means that the data you collect can help you respond more effectively to your research 
questions. This study applied the method of qualitative analysis and a multiple case study design. 
The qualitative methods of investigation was used to collect and analyze data, identify emergent 
themes and produce recommendations about the experiences of pharmaceutical staff that has 
challenged by the rising cost of hospital pharmaceuticals and their impact on patient care. 
Population and Sampling 
Discussion of Population. Research studies are performed on a population sample, rather 
than using a whole population. The most challenging part of fieldwork is to draw a random 
sample from the target population, which would generalize the results of the study (Banerjee & 
Chaudhury, 2010). Population selection is a prerequisite in the qualitative as well as quantitative 
studies documentation. However, both designs also apply the principles of accessible, general, 
and target populations. The accessible population is the participants that are willing and able to 
participate. The general population is any individual that might fit in with the aim of the research 
study. The target population is the participants who fit into the selection criteria for the research 
study (Asiamah et al., 2017).  
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For qualitative and quantitative research, however, population definition is not motivated 
by the same principles. Quantitative research requires the involvement of a relatively large 
number of people who are not needed to describe the experiences and anomalies thoroughly in 
the review (Creswell, 2003). On the other hand, a qualitative study focuses on relatively few 
participants who can explain their perceptions and knowledge about specific questions or 
phenomena in research. Furthermore, participants' explanations of interactions in specific detail 
form the basis for discussing qualitative research goals (Baškarada, 2014; Creswell, 2003). The 
population will consist of hospital pharmacists and pharmacist supply chain staff for this study. 
Discussion of Sampling. Purposeful sampling is a method commonly used in qualitative 
research to recognize and pick cases rich in knowledge for the most productive use of limited 
resources, especially informed about a phenomenon of concern or familiar with it (Creswell & 
Plano Clark, 2011). Creswell and Poth (2018) theorized that a purposeful sampling approach 
helps the researcher to select the participants and locations for the case study that can provide an 
understanding of the study's research issue. Pharmacists are responsible for reducing the effects 
of pharmaceutical shortages by collecting data and tracking the shortage and maintaining contact 
with the manufacturer's local representatives (Kaakeh et al., 2011). Hospital pharmacists spend 
much time managing supply disruptions and drug shortages. Hospital pharmacists in the United 
States spent about 9 hours a week on drug delivery problems, while hospital technicians spent 8 
hours a week (De Weerdt et al., 2015).  
This qualitative research used fewer study participants to get a more in-depth 
investigation per subject. Utilizing the technique of purposeful sampling, the appropriate 
pharmaceutical and pharmaceutical inventory staff were surveyed until nothing new emerged 
from the study. 
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Summary of Population and Sampling  
To participate in this research study, participants needed to be 18 years of age and older, 
possess a Bachelor's degree in pharmacy management, supply chain management or a related 
field, currently work in the field of hospital pharmaceuticals or pharmacy inventory management 
in the New York City and Long Island area, and have at least two years of work experience in 
hospital pharmaceuticals or pharmacy inventory management. The participants' research criterion 
would limit the population number to a sample that could better fulfill the study's goals. 
Data Collection 
A feature of many qualitative studies is data collection by interviews with participants. 
The data collected for a particular research issue is known as primary data. Interviews offer the 
most apparent and concise approach to gathering detailed and rich data on a specific 
phenomenon. With the primary methods of data collection, a researcher can gather data from the 
participants ' direct responses. The type of interview used to collect data can be tailored to the 
research question, the characteristics of participants, and the preferred approach of the 
researcher. Interviews are most often carried out face-to-face, though the use of telephone 
interviews to overcome geographical barriers to participant recruitment is becoming more 
prevalent (Smith, 2005). An electronic interview is one form of interview which is an alternative 
to the conventional method. Unlike others, this approach may be used to analyze the behaviors, 
viewpoints, values and individuals' experiences in the study. These interviews may be conducted 
concurrently and asynchronously. In the concurrent process, the interviewer interacts 
simultaneously with the interviewees. Some examples are telephone calls, use of webcams and 
chatting on social networks. Asynchronous interviews are the ones where interviewer and 
interviewee engage at various times in an interview. Examples of asynchronous interviews are e-
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mails, online forums, online questionnaire or social network sites (Parvaresh-Masoud & Varaei, 
2018). 
Instruments  
The researcher is the main instrument of data collection and interpretation in qualitative 
research (Stake, 2010). It is through the researcher's facilitative commitment that a 
conversational space is a domain where respondents feel secure about sharing tales about their 
experiences (Owens, 2006). In a good case study, interviews, reports, archival records, 
documentation, and visual materials are excellent sources for data collection and analysis 
(Creswell, 2016). The researcher used the Interview Guide as set out in Appendix A; a method 
adapted from Asmussen and Creswell (2016). According to Annum (2014), a standard method of 
data collection in qualitative research is the semi-structured interview. The thorough creation of a 
qualitative semi-structured interview guide adds to the studies ' objectivity and legitimacy and 
makes the findings more probable (Kelly, 2010). For this analysis, the interview guide consisted 
of a collection of specific questions for each participant. Before the interview, the questions were 
decided upon and formulated using the interview guide. The participants of the study also had 
the option of completing the interview in writing and submitting the responses via email. 
The interview guide addressed the study's core subjects. It provided a structured 
framework for conversation during the interviews. The aim was instead to broaden the research 
area by collecting related kinds of information from each participant, by guiding what to speak 
about to the participants (Holloway & Wheeler, 2010). The researcher determined it was most 
fitting to use substantive comprehensive, open-ended knowledge questions. The researcher 
should have continued with an introduction after the introductory portion of the interview guide 
was done. The researcher then discussed the purpose of the study and secured signed informed 
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consent. The next step was to provide the structure for the interview and ask the participants if 
they had any questions before the interview began.  
The first set of questions explored the professional and educational history of the 
participants. It was essential to know precisely how much experience the pharmacists, 
technicians, and inventory staff have with pharmaceuticals, more precisely, shortages. The next 
set of questions were the content questions, focused on research questions and sub-questions. 
The researcher considered this to be the core of the interview. The questions in this section began 
with the history of pharmaceutical shortages inside the hospital of participants; the 
manufacturer's position in hospital shortages; the steps are taken, if any, to mitigate or avoid the 
shortages. In the interview, the final set of questions discusses the use of data in pharmaceutical 
shortages and whether predictive analytics is an appropriate predictive strategy. 
Data Collection Techniques  
Interviews and document reviews are the two forms of data collection techniques used in 
this study. According to Moser and Korstjens (2018), in qualitative research, interviews are 
among the most common data collection methods. Before collecting data, the researcher had 
received the requisite permits from the Internal Review Board (IRB) of Liberty University to 
work with human participants. After securing permissions, the researcher connected with the 
IRB department of each hospital. The Hospital's IRB also has guidelines in place to protect the 
patients and the participants of this study. Once the hospital IRB gives their approval, the 
research can contact the sample of the population that can best support the study. This study 
included interviews with Pharmacists, Pharmacy Technicians, and Pharmaceutical Inventory 
Staff. The goal was to interview 10-15 participants for this study. The researcher used personal 
contacts as well as LinkedIn to contact potential participants. 
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The semi-structured interview was conducted by the researcher to get as much raw data 
from the viewpoint of each participant (Creswell & Poth, 2018). The researcher anticipated 
numerous amounts of data from the interviews. The best way to keep track of the data was by 
using a recording device. As a part of the participant's consent, the researcher recorded the 
interview. Also, many researchers may create a "field notes" folder to accompany audio-taped 
interviews. Field notes enable the researcher to maintain and track observations, environmental 
conditions, attitudes, and nonverbal signals, which may not be appropriately captured by audio 
recording (Moser & Korstjens, 2018).  
Data Analysis  
Qualitative research data analysis is the process of methodically searching and organizing 
the transcripts of interviews, field notes, or any other non-textual information collected by the 
researcher to improve the interpretation of the phenomenon. The method of evaluating 
qualitative data requires mainly the coding or categorization of data (Patton, 2002). In qualitative 
studies, coding is the essential phase in the data analysis. It fundamentally includes making sense 
of enormous amounts of data by reducing the volume of raw information, finding significant 
patterns, and ultimately drawing meaning from data and creating a logical chain of evidence 
afterward (Wong, 2008). Codes are tags or marks intended to assign identified themes or topics 
from the data compiled in the analysis. Patton (2002) coding has historically been done 
manually, using colored pens to classify data and then cut and sort data. Given the advancement 
of information technology, qualitative researchers are increasingly using electronic methods of 
coding data (Roberts & Wilson, 2002). In the end, the researcher must still synthesize the data 
and decode the meanings extracted from the data. The use of computers in qualitative analysis 
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has, therefore, merely made data organization, reduction, and storage more proficient and 
manageable (Wong, 2008). 
Reliability and Validity 
Reliability  
Reliability is the degree to which the findings can be replicated on the same conditions 
when the work is repeated (Yin, 2014). Bloomberg and Volpe (2019) reported that if qualitative 
work is accurate, then consistent findings will be made by researchers investigating the same 
phenomenon. This research would illustrate reliability by continuously using the same 
methodology and procedures to ensure that each participant has the same opportunities for semi-
structured interviews to identify and explain their perspectives. Reliability was achieved for this 
qualitative study mainly through a detailed and reliable interview process, guided by a semi-
structured interview guide, and thorough interview recording transcripts. Lack of reliability in a 
study may lead outside reviewers to become skeptical of case studies as a form of analysis (Yin, 
2014). The goal of reliability is to diminish bias and errors within the study (Yin, 2018). This 
study used triangulation to test both reliability and to show the reliability of the data and findings 
obtained. Triangulation refers to the use of several approaches or data sources to establish a 
detailed understanding of the phenomenon in qualitative research (Patton, 1999). During the 
analysis, the researcher made specific observations helping to provide data on the phenomenon 
for testing. 
Validity 
Validity in qualitative research means that the methods, procedures, and data are correct. 
Construct validity makes sure the study's operational measures are correct (Yin, 2018). The 
semi-structured interview was ideal for gathering the data needed to address the research 
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questions, as the interview guide gave the researcher a template to follow while collecting the 
data. The first part of the interview guide is the tool used to collect basic data about the 
participant’s education and experience with hospital pharmaceuticals. The second part of the 
interview guide helps the researcher collect data about the content. The content data evaluate the 
experience of the participant in their respective New York hospitals is in shortage of 
pharmaceuticals. This study defines manufacturing as a cause for pharmaceutical shortages, so 
the participants are asked about the impact of drug shortages because of manufacturing issues. 
The final part of the interview guide explores the theory of using data, specifically predictive 
analysis, as a potential solution to decrease the increasing pharmaceutical costs of hospitals. The 
semi-structured interview guide allowed the researcher to probe the respondents when they 
needed clarification of their answers and more in-depth insight into a specific viewpoint. The 
interviews helped the researcher to gather data on each of the themes found.  
Fusch and Ness (2015) noted that researchers use saturation to determine when there is 
sufficient data from a study to create a reliable and accurate understanding of the research 
phenomenon. With saturation, a researcher can reasonably be confident that further data 
collection can produce similar results and help to validate emerging trends and conclusions. If 
researchers may claim to have collected enough data to accomplish their research objective, they 
should disclose how, where, and to what degree data saturation achieved. Failure to attain data 
saturation affects the consistency of the research performed and hampers the validity of the 
content (O'Reilly & Parker, 2012). There is a clear connection between the triangulation of data 
and saturation of data; one (triangulation of data) guarantees the other (saturation of data). In 
other words, data triangulation is a way of achieving data saturation (Denzin, 2012). 
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Transition and Summary of Section 2 
This qualitative case study examined the rising costs of hospital pharmaceutical shortages 
and the impact on patient care: exploring the use of predictive analytics in New York area 
hospitals. The role of the researcher was to act as a facilitator. The researcher identified 
participants, conducted an interview, and analyze the data from the interviews. The participants 
included pharmacists, pharmacy supply chain managers, and clinical support staff that have 
experience with hospital pharmaceuticals and shortages. This study used the qualitative research 
method and the qualitative case study research design. The target population included the 
participants that fit into the research study selection criteria. The data collection method for this 
study was semi-structured interviews. The instrument was the researcher and the interview guide. 
The data, collected via transcriptions and field notes, was organized, analyzed, coded, and 
themed. The main component of all work is validity and reliability. Careful attention to these two 
things will make the difference between good research and bad research and can help ensure that 
the results are reliable and trustworthy. 
The third section of this study included the overview of the study on the rising costs of 
hospital pharmaceutical shortages and the impact on patient care: exploring the use of predictive 
analytics in New York area hospitals. Section 3 continued with the presentation of the findings, 
applications to professional practice, which includes implications of findings and biblical 
framework and field of study. The final part of Section 3 consisted of the recommendations for 
further study, reflections of the researcher’s experience, and the summary and study conclusions. 
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Section 3: Application to Professional Practice and Implications for Change 
The last section starts with a study overview. Next, the researcher presents the findings 
and discusses professional practice applications. The application follows recommendations for 
action and prospects for future research. The researcher reflects on the experience, including 
personal prejudices, thought shifts, and the study findings from a biblical worldview. This 
section will conclude with an analysis of the overall study, including proposals for further studies 
on pharmaceutical shortages in hospitals. 
Overview of the Study 
This study examined the rising cost of hospital pharmaceutical shortages and the impact 
on patient care. It further explored the use of predictive analytics as a tool to forecast and 
potentially reduce costs. Hospital pharmacists worldwide are challenged with ensuring a growing 
number of patients receive sufficient medication supplies while preserving the financial balance 
of pharmacy budgets (Juhász et al., 2016). Various factors can cause shortages of 
pharmaceuticals, but the fundamental causes that may occur within hospital pharmacies are 
issues with manufactures, lack of data and communication flow, increased demands, inadequate 
inventory control, changes in clinical practice, and natural catastrophes (Shrestha et al., 2018). 
The recent effects of COVID-19 on hospital pharmaceuticals have made the FDA regulate the 
supply chain of prescription goods strictly in the anticipation that it may be impacted by the 
COVID-19 outbreak, possibly leading to delays of supply or shortages of drugs products in the 
United States. FDA recognizes the considerable effect this can have on patient care and is doing 
everything to help avoid and mitigate shortages in healthcare institutions (FDA, 2020).  
This study aimed to understand the factors behind the rising cost of hospital 
pharmaceutical shortages relating to manufacturing problems and the impact on patient care. The 
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researcher used the methodology of a qualitative case study to provide the tools to study complex 
phenomena within their context. Upon proper implementation of the method, developing theory, 
reviewing projects, and designing strategies is a valuable tool for health science study (Baxter & 
Jack, 2008). The researcher conducted interviews virtually and in writing to answer the research 
questions:  
 RQ1. How are hospitals challenged by the rising costs of hospital pharmaceutical 
shortages due to manufacturing problems?  
 RQ2. What role does supply and demand management play in hospital pharmaceuticals? 
 RQ3. How would predictive analytics improve patient care inefficiencies relating to 
rising costs of hospital pharmaceutical shortages?  
From these questions, the researcher constructed open-ended interview questions for 
participants to answer (Appendix A). The researcher was able to create a more comprehensive 
picture of the phenomenon by interviewing multiple people with different experiences. 
After receiving the approval from Liberty University's IRB, the researcher reached out to 
potential participants who would be qualified to participate. Participants needed to be 18 years of 
age and older possess a Bachelor's degree in pharmacy management, supply chain management 
or a related field, currently work in the field of hospital pharmaceuticals or pharmacy inventory 
management in the New York City and Long Island area, and have at least two years of work 
experience in hospital pharmaceuticals or pharmacy inventory management, and are willing to 
participate. Participants had to have experienced pharmaceutical shortages at the hospital where 
they work. The researcher initially planned to conduct interviews in person; however, due to the 
current COVID-19 pandemic, social distancing, and city lockdowns, interviews had to be done 
virtually or in writing. The recruitment of potential participants included the use of phone, email, 
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and LinkedIn messenger. Out of the 28 potential participants contacted, 10 were qualified and 
agreed to participate. Three of the participants were from hospitals in Long Island, and the 
remaining seven were from hospitals in the New York City area. A 3-digit and 2-letter identifier 
was assigned to each participant to protect the privacy of the participant. The presentation of 
findings addressed research questions along with quotations from study participants. 
Anticipated Themes/Perceptions 
During the interviews, the researcher had anticipated hearing particular themes before the 
data collection. Such perceptions and themes resulted from the vast amount of studies and papers 
read during the literature analysis process. The researcher anticipated the participants would 
agree that hospital pharmaceutical shortages have adverse effects on patient care, such as 
insufficient treatment, under-optimal care, delayed or surgery cancellation (Rosoff, 2012). 
Furthermore, drug shortages can challenge the patient-physician relationship. It was also 
perceived that pharmacist would say that they are one of the first to face pharmaceutical 
shortages in hospitals. There was great anticipation that data would play a significant role in 
pharmaceutical inventory, either not being reliable for the lack thereof. The researcher perceived 
that there would be similarities in the highest cases of pharmaceuticals. 
During this study, the world entered into a global pandemic, Coronavirus, or COVID-19. 
The researcher anticipated the discussion of the effects of COVID-19 and pharmaceutical 
shortage would dominate any other shortages that hospital pharmaceuticals face. Moreover, the 
researcher expected that there would be a theme of health systems banning together to tackle the 
most difficult of shortages to ensure the entire health system is covered. 
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Presentation of the Findings 
This qualitative research study examined the rising cost of hospital pharmaceutical 
shortage and the impact on patient care. Furthermore, this study explored the use of predictive 
analytics as a possible solution to reduce costs. This study's general findings were based upon 
cases from 10 participants who worked in hospitals in New York City and Long Island. The 
sample resulted in the following demographics: 
Figure 2  
Participant Demographics 
 
 
Due to the academic requirement of a bachelor's degree, the researcher could not qualify 
for potential participants in the population. Each participant had relevant knowledge of hospital 
pharmaceutical shortages at different levels of the supply chain process. Early in data collection, 
the researcher learned that a significant pattern occurred, which would change the study's 
anticipated results. That pattern would be the novel Coronavirus (COVID-19) effects and the 
havoc it wreaked on hospital pharmaceuticals and patient care. The data were collected and 
triangulated by interviewing 10 participants from hospitals in New York City and Long Island. 
The participants had sufficient experience in pharmacy and medication shortages. After the 
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seventh participant, saturation was reached as it became evident that no further new information 
would emerge. 
Section 3 also described the themes that emerged from the study and how the themes 
relate to the research questions. This section of writing also includes several quotes from 
participants. Last, this section of the writing consists of a summary of the findings. 
Qualitative Data Analysis 
This section will present the data by theme/pattern/relationship. The researcher used 
interview transcripts and written interview responses to develop emerging themes through the 
open coding process, based on the main concepts. After the open coding process, axial coding 
was conducted to create categories from the concepts and connections through the emerging 
themes (Williams & Moser, 2019). The researcher used Microsoft Excel to organize and 
examine the data. The themes that emerged from this qualitative multiple case study included 
manufacturing issues are the main cause of hospital pharmaceutical shortages, supply and 
demand management is just as challenging as shortages, and there are pros and cons to using 
predictive analytics. The concepts were essential for the rising cost of hospital pharmaceuticals, 
and the impact of patient care, exploring the use of predictive analytics. The questions and 
information gathered in the literature review were also related to the research findings. 
Furthermore, within the conceptual framework, there was an in-depth exploration of the themes 
and relationships. Table 1 illustrates the major and minor themes relating to the research 
questions. 
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Table 1  
Major and Minor Themes 
 
 
Emergent Theme Relation to Research Questions 
 Research Question 1. How are hospitals challenged by the rising costs of hospital 
pharmaceutical shortages due to manufacturing problems?  
MajorTheme 1/Research Question 1  
 The major theme of the first research question is, "Manufacturing issues are the primary 
reasons for hospital pharmaceutical shortages." Interview questions 1a, 1b focused on hospital 
pharmaceutical shortages due to manufacturing problems. Drug shortages may be related to 
manufacturing problems such as manufacturing or quality issues, API problems, failure to 
comply with regulations, capacity, or quality issues, to name a few. A problem encountered at a 
single manufacturing site may well lead to significant disruptions in the global market. All 
 Research Question Major/Minor Theme 
1 How are hospitals 
challenged by the rising 
costs of hospital 
pharmaceutical shortages 
due to manufacturing 
problems? 
Manufacturing issues are the primary reasons for 
hospital pharmaceutical shortages. 
Alternatives/Replacement Pharmaceutical 
Raw Material Shortage 
Natural Disasters 
2 What role does supply and 
demand management play 
in hospital pharmaceutical 
shortages? 
 
Supply and demand management is just as challenging 
as shortages. 
Greater Transparency 
Prepared for Shortages 
COVID-19, the global pandemic 
3 How would the use of 
predictive analytics 
improve patient care 
inefficiencies relating to 
rising costs of hospital 
pharmaceutical shortages? 
There are pros and cons to using predictive analytics.  
Pros & Cons & COVID-19 
87 
 
participants agreed that manufacturing issues were the primary reason for hospital shortages 
(Bogaert et al., 2015). 
Minor Theme 1. Minor theme 1 is alternatives/replacement pharmaceuticals. Drug 
shortages affect individual services for patients, families, hospitals, and public health. Patients 
should be notified before receiving alternative pharmaceutical treatment. Alternative drugs are 
occasionally approved in a hurry, and sometimes patients are the last to know about the 
necessary changes in treatment. Although such alternatives may produce something the same or 
better, they often have no impact, or even worse (Scott et al., 2015).  
Participant 004 responded that the physician and pharmacy leadership, along with any 
related specialists, will meet and assess supplies and any appropriate alternatives. The 
nature of the shortages and alternative medicines used will be communicated to all 
providers, nurses, and pharmacists. 
Participant 008 commented that getting substitute drugs during shortages is very 
challenging. 
According to Gray et al. (2005), the provision of alternative medicines by substitution must be 
made with the patient's consent. It is agreed that pharmaceutical replacement is best performed 
only in hospital settings. It is vital to formulate a clear strategy for the introduction of 
pharmaceutical substitution with all concerned.  
Participant 007 remarked, the most significant challenges that occur with pharmaceutical 
shortages are finding a replacement product and then having to communicate the change 
and provide any necessary education regarding the replacement product to the end-user. 
The goal is patient safety, and we never want to introduce a product that can cause 
confusion on the part of the nursing staff and cause harm to any patient.  
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The patient is more likely to be satisfied and grateful if the unavailability of the prescribed 
medicine and its substitute is explained. The hospital makes every effort to obtain and supply the 
medication that was initially prescribed (Assefa et al., 2011). 
Participant 009 replied that whenever we replace a medicine, we provide something the 
treating physician didn't intend to do. But if we are unable to provide medicines that 
make what we do successful, then all our efforts will be for nothing. 
Minor Theme 2. Minor theme 2 is the raw material shortage. According to Caldwell et 
al. (2016) manufacturers should ensure that environmental protection is a crucial criterion when 
awarding work to their subsidiaries or third-party organizations, regardless of where they might 
be situated in the world when it comes to APIs. Medicine shortages can lead to higher costs and 
reduced quality and safety of treatment, as unavailable drugs continue to be replaced by much 
less effective medicines, which can be much more costly (Horgan & Doeswijk, 2017). 
Participant 007 stated the raw material shortage also referred to as a shortage in Active 
Pharmaceutical Ingredients (API), can lead to multiple manufacturers unable to produce 
products, thus creating a lack. API comes from China and India, and any issues that occur 
that are related to the quality of API coming out of these countries will lead to drug 
shortages. 
Participant 003 adds that manufacturers have to ensure up their API (active 
pharmaceutical ingredients) from vendors they may be getting at the same time. Such 
shortages are especially troublesome when several producers are affected by a primary 
source supplier of raw material delays or discontinuing production. 
Another common explanation behind medication shortages are shortages of raw material for the 
manufacture of active substances or other ingredients (Heiskanen et al., 2017). Raw material 
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shortages are a global problem, partially because the consequence is a small number of operating 
companies with lengthy or complicated supply chains. 
Participant 006 stated that the problem arises when many finished goods producers rely 
on subcontractors, who depend on a specific dealer of raw materials. The raw material is 
not transferred to the subcontractors and on to the producers when the raw material dealer 
faces their production quality problems. 
Minor Theme 3. Minor theme 3 is natural disasters. Natural disasters can have a 
significant impact on the supply of pharmaceuticals. Completed pharmaceuticals or suppliers can 
be affected by floods, hurricanes, fires, and tornadoes. Destruction to manufacturing facilities 
caused by natural disasters, mainly if the site-produced product is a sole-source product, can 
cause long-term shortages (Fox et al., 2009). A shortage of many medications occurred in Puerto 
Rico in 1998 when hurricane George destroyed pharmaceutical facilities. In 2005, hurricanes 
Katrina and Rita resulted in a spike in demand for and a shortage of such medications. 
Participant 008, replied all pharmacies should have contingency plans for shortages and 
emergency purchases of medicines. Natural disasters can worsen drug shortages as they 
generate increased demand for the medications needed to treat the victims of disasters. 
Participant 005 comments there have been many shortages in the last eight years due to 
materials shortage or natural disasters like hurricanes. After Hurricane Sandy, a lot of 
pharmacies were closed, and people could not get their medications. 
In September 2017, Hurricanes Irma and Maria hit Puerto Rico. The loss of power and water 
supply, severe flooding, and the deterioration of communications presented Puerto Rican citizens 
with a big challenge. The pharmacist's functions follow a disaster in such settings that include 
both clinical services, such as providing direct patient care and logistical services, such as 
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managing drug delivery. As pharmacists' role expands throughout health care, making use of 
their skills during a disaster might increase access to care (Jiménez-Mangual et al., 2019). 
Participant 009, replied that ensuring that the supply chain for health care works reliably 
and without interruption during natural disasters requires active cooperation across the 
healthcare sector. 
 Research Question 2. What role does supply and demand management play in hospital 
pharmaceutical shortages? 
Major Theme 2/Research Question 2  
 The major theme for the  research question 2 is that supply and demand management is 
just as challenging as shortages. Interview questions 2.b, 2.c focused on the pharmaceutical 
shortage challenges and the role of supply and demand. All the participants agreed that problems 
with the supply and demand for prescription products constitute a significant concern that 
concerns healthcare organizations. Hospitals can reduce the impact of shortages by creating a 
robust supply and demand management system before they occur (Fox & Tyler, 2017). Changes 
in demand were often triggered by daily seasonal market fluctuations and shortages faced by 
many pharmaceutical firms, which was almost impossible to foresee (Heiskanen et al., 2017). 
Drug supply problems are an increasing and global problem. Pharmacists at the hospital are 
trying to manage the drug supply problems to minimize the impact on patient care (De Weerdt et 
al., 2017). 
Participant 004, replied that when a shortage is detected, pharmacy workers will 
determine the on-going inventory and estimate the period covered by it. Also, having a 
second drug wholesaler can be beneficial. 
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Managing inventories is challenging in the face of shortages. Pharmacists at the hospital 
spend a great deal of time handling supply delays and drug shortages. In the United 
States, hospital technicians spent about 8 hours a week on drug delivery problems, while 
hospital pharmacists spent 8 hours a week. Although preparing for any possible shortage 
is unrealistic, careful preparation will minimize adverse effects on medical care costs and 
coordinate healthcare and avoid crises from escalating into a crisis. (De Weerdt et al., 
2017) 
Participant 002 stated that hospital supply chains are incredibly effective at what they do; 
however, in the middle of a pandemic that requires pharmaceutical drugs of all kinds, you 
can never be fully prepared. 
Participant 010 said a team called procurement and strategic sourcing (PSS) in the supply 
chain field. This team focuses on the acquisition of supplies/drugs in situations such as 
back-orders, and this is directly related to drug shortages, which means that with history, 
natural disasters (Hurricane Katrina), we've been through a lot and come through, this 
shows preparedness for anything. 
 The highest case of shortages according to each participant is captured in Figure 3.  
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Figure 3  
Most Common Pharmaceutical Shortages 
 
 
 
Minor Theme 1. Minor theme 1 is supply chain preparedness. In some hospitals, there is 
first a supply disruption. A supply disruption can quickly turn into a supply shortage if not 
resolved correctly. When hospital pharmacists are aware of the possibility of a shortage of 
medications, they frequently search for alternative products from other sources. When many 
hospital pharmacists order from the same manufacturer the same alternative drug, the latter 
manufacturer may not be able to satisfy the unexpectedly increased demand, resulting in a 
domino effect of supply issues with various suppliers (Caulder et al., 2015).  
When asked if the participants felt that their hospitals were prepared for shortages, the 
answers varied. These responses were based on daily supply chain shortages, and when it came 
to the novel Coronavirus, their perceptions were different from those addressed in the minor 
theme 3. Inefficient pharmaceutical supply chain management activities often contribute to 
significant shortages and inefficiencies in supplying essential healthcare supplies. A shortage 
happens when a product is not available commercially to meet the demand (Saedi et al., 2016).  
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Participant 001 replied that their hospital was not prepared for pharmaceutical shortages. The 
type of distribution system that a hospital has makes a difference. Space is minimal at the 
hospital; if I wanted to buy bulk pharmaceuticals, there is no space to store them.  
Participant 010 replied that their hospital is not as prepared as it should be. Since several 
of these triggers are unavoidable, they are working to properly manage a hospital 
inventory to reduce shortages and improve treatment standards. 
Given the unpredictable effect and complex existence of drug shortages, organizations 
must establish a triage plan for threatened on-hand pharmaceutical supplies (Rhodes et 
al., 2016). 
Participant 007 and Participant 005 agreed that supply and demand is the key issue with 
drug shortages, and that they are prepared for shortages.  
Participant 003 stated that they are in better shape than they were ten years ago. In their 
hospital, it is the norm. Moreover, given the severity of the shortages from a quality of 
care and cost perspective, the goal is to reduce national hospital shortages. 
Minor Theme 2. Minor theme 2 is greater transparency. Drug shortages tend to be 
complicated by uncertainty about the nature and quality of the information available and the 
duration of the shortage. Lack of transparency leads to the current shortage of drugs, a crucial 
health care problem that restricts treatment choices, reduces access to medicines, and may 
jeopardize patients' well-being in need of substantial therapies (Rhodes et al., 2016).  
Participant 001 said that only a handful of primary suppliers in the world could be 
supplying the raw shortage of goods for most of the generic products. And while they 
rely heavily on them, there is not much transparency. 
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Participant 003 replied that it would be helpful if a manufacturing plant needs to shut 
down; they can let the competitors know to step in and meet the market demand. It may 
not make sense for the competitor to share information like that, but it will help the 
hospitals in which they live from an ethical perspective. 
Transparency in the data available on the supply chain could help to prevent future drug 
shortages. Pharmaceutical manufacturers usually know where the drug raw materials originate. 
But these data are kept confidential by every company, and even the F.D.A. has no structured 
way of looking at drug development and supply chain efficiency (Bogaert et al., 2015). 
Participant 007 agreed that there should be more transparency, such as using the 
information obtained from the wholesalers and buyers who work directly with the 
manufacturers to see if it is an actual shortage or just delays in shipping products to the 
wholesalers. If need be, they should place direct orders with the manufacturers to bring in 
the product before it goes to the wholesaler. 
Minor Theme 3. COVID-19, the global pandemic. COVID 19 caused a massive shock to 
the demand for healthcare systems that are already running close to full capacity. The 
coronavirus pandemic directly affects the supply chains of nearly every manufacturer, retailer, 
and wholesaler. While the world continues to maneuver through this hard period, most 
businesses struggle to continually supply the products and services needed (Sharma et al., 2020). 
Every participant has their own experience of how COVID-19 affected hospital pharmaceuticals. 
Participant 010 replied that managing the demand requires efficient approaches to control 
patient care's resource supply. It is not an easy job when coping with a highly infectious 
disease such as COVID-19. 
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Participant 003 noted that this whole pandemic would change how the inventory is 
managed; typically, they want to be lean as much as possible. Still, in the light of what 
has happened, it will change the way inventory is managed. Like, for example, instead of 
trying to keep a very minimal supply on hand, people feel more comfortable having a lot 
more on the side just in case. 
 COVID-19 has affected the supply chain and its ability to respond to the crisis. Personal 
protective equipment, masks, ventilators have been hit hardest by supplies. The scarcity is 
attributed to the susceptibility of the supply chain. For instance, China has been producing 
approximately half the world's face masks before COVID-19. However, with COVID-19 
spreading across China, the country could not export the necessary medical pieces of equipment 
(Sharma et al., 2020). The best way to capture the impact is through the eyes of the practitioners 
who struggle firsthand. 
Participant 008 stated hospitals need to review their supply chain methods, supply chain 
structures, and supply chain interactions to prevent behavioral responses to potential 
pandemics and train themselves to handle unforeseen disruptions. 
Participant 007 replied that they are fortunate to be a part of a health system. As such, 
they can move needed product around to hospitals that may have run out of a product. 
The shortages occurring during COVID-19 were related to increased demand over and 
above a hospital's typical purchase pattern. Hospitals needed more products than they had 
previously ordered, and drug wholesalers were not ready. To mitigate shortages, they 
went directly to the manufacturer for the product, enabling them to obtain the number of 
products needed to treat our patients. 
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Participant 002 commented that they anticipated a shortage due to COVID-19. They 
contacted all of their partners in the pharmaceutical world to see if they can order in bulk. 
They received a bulk shipment of drugs, and that has helped them stay afloat. The only 
other thing they can do is follow the FDA's guidance as they work closely with 
manufacturers. 
 Research Question 3. How would the use of predictive analytics improve patient care 
inefficiencies relating to rising costs of hospital pharmaceutical shortages? 
Major Theme 3/Research Question 3 
 The major theme for the 3rd research question is that there are pros and cons to using 
predictive analytics. Interview questions 5, a-d focused on the thoughts of using predictive 
analytics as a forecasting tool. Most healthcare systems are struggling to control rising costs and 
effectively distribute scarce resources. Predictive analytics can help find an individual choice of 
drugs for each patient, which can reduce costs. Predictive analysis involves extracting 
information from existing data sets with an appropriate degree of accuracy and reliability to 
forecast results and trends. Predictive analytics is a method by which data is analyzed and 
modeled using machine learning (Jhajharia et al., 2015). Nine of the ten, the participants were 
familiar with predictive analytics, but their views differed about it being a tool that will help with 
forecasting and preparing for shortages. However, six of the ten participants related using 
predictive analytics with COVID-19 pharmaceutical shortages.  
Participant 001 replied that predictive analytics would help to confirm potential 
shortages. It would be difficult for a system to know that this is a shortage and that this is 
going to be a problem and that this other drug, which is also useful in this situation, is 
also going to be in short supply because there are just so many different indications that it 
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would be too complicated for a system to narrow it down. However, for COVID-19, it 
may be easier to determine, mostly because they have seen the types of medicines used to 
treat most of these patients, and they are better able to look at the supply chain and see 
which ones will be more problematic. 
Participant 007 replied that on a typical day, a predictive model might help predict 
shortages for their most common pharmaceuticals, but for COVID-19, all they can 
predict is that it maybe ten times worse the second time around.  
Participant 009 was not aware of predictive analytics until the researcher gave the 
definition. After the explanation, they replied that it might have been a great tool to use 
with the COVID-19 pharmaceutical shortages, but only after the third week into the 
pandemic, as they had what pharmaceuticals were needed initially. 
Participants 002 and Participant 005 felt that predictive analytics was a new science that 
would need further study. 
According to Sohrabi et al. (2019), pharmaceutical marketing and sales managers in 
hospitals also work with massive marketing and sales data quantities. One of their most 
significant issues is to consider the effects of drug shortages. Data mining finds and removes 
useful patterns to identify secret and worthy decision-taking trends from these large data sets.  
Participants 004 and 006 commented that pharmaceutical managers want to change and 
enhance their current marketing contacts and introduce brand building strategies to gain 
competitive advantage. They thought that predictive analytics should prioritize and define 
patterns so that marketing and sales managers would plan effectively and optimally to 
avoid wasting time and resources, better manage their medical representatives and 
contribute to higher pharmacy sales. 
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Providers use data from their health information system to identify trends and patterns in 
drug use in hospital pharmacies and establish strategies wherever possible to repackage bulk 
drugs into smaller unit dosages (Malik et al., 2018). 
Participant 009 later remarked that predictive analytics may be beneficial in the 
repackaging exercise. 
Participant 010 stated that the robustness of the data will depend on this. Often there are 
shortages due to freak chances such as earthquakes, COVIDs and other impactful events. 
Opportunities should be given to the pharmaceutical industry to manufacture medicines 
for the smaller classes. In other words, if they are found not to help all of those who have been 
prescribed, previous large bulk medications will certainly be less used. Old drugs should be put 
back, discarded because the hospital did not use them, as drug manufacturers would find it 
economically viable to do so (Malik et al., 2018). 
Relationship of Themes to Conceptual Framework and Literature Review 
The themes and patterns presented in the findings align with the focus of the conceptual 
framework and the literature review in the first section of the study. Table 2 illustrates the 
relationship of the themes to the conceptual framework and literature review. 
Table 2 
Theme Relation to Conceptual Framework and Literature Review 
 
Research Question 1 – Theme - Manufacturing issues are the primary reasons for hospital 
pharmaceutical shortages. How are hospitals challenged by the rising costs of hospital 
pharmaceutical shortages due to manufacturing problems? 
The importance of hospital pharmaceutical efficiency. Deficiencies in the prescription and 
excessive use of pharmaceuticals can cause financial losses and affect patients in a significant 
way. According to Bogaert et al. (2015), shortages due to manufacturing problems typically 
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last longer than those due to supply chain problems. Thus, when a manufacturing problem 
arises, a whole supply chain is often needed to be withdrawn from commission. 
Rising costs of hospital pharmaceuticals shortages. Pharmaceutical shortages of drugs have 
become more frequent and progressively severe since 2004. Also, shortages have a greater 
impact on patient care and have become longer in duration. The increase in healthcare costs 
would empower hospitals to strategically plan the supply chain so that they can manage prices, 
predict demand shortages, and better meet their healthcare needs (Edmunds, 2016). 
Research Question 2 – Theme – Supply and demand management is just as challenging as 
shortages. What role does supply and demand management play in hospital pharmaceutical 
shortages? 
Pharmaceutical supply and demand management. The components of a hospital 
pharmaceutical inventory are a sizeable operating expense. Most health facilities and 
emergency departments face difficulties in achieving successful inventory control as they have 
neglected how pharmaceuticals are regulated, distributed, and used to save lives and improve 
well-being (Uthayakumar & Priyan, 2013). 
Research Question 3 – Theme –There are pros and cons to using predictive analytics. How 
would the use of predictive analytics improve patient care inefficiencies relating to rising costs 
of hospital pharmaceutical shortages? 
Business strategy and predictive analytics. Implementing a business plan and developing 
procedures would help handle the pharmaceutical inventory in hospitals. Usage of the most 
innovative cutting-edge front-line technologies is critical to stay competitive and essential in 
today's markets. For supply chain executives, aiming to improve today's fragmented supply 
chains' adequacy, critical predictive analytics is a learning gathering that can help increase 
productivity and reduce costs (Parniangtong, 2016). McKesson (2019) suggested predictive 
ordering (analysis) is a strategy that can improve the hospital supply chain of pharmaceuticals 
by using data to track ordering habits. With the data, the percentage of manual ordering 
decreases while the focus of ordering standardization increases. 
 
The researcher concluded that data saturation was reached after completing seven out of 
the ten interviews, as participants were giving no new input. According to Creswell and Poth 
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(2018), data saturation is the stage where sufficient knowledge was collected to establish an 
analysis in full. Additionally, the data collected were triangulated by comparing the cases and 
identifying commonalities and differences among participant responses. According to Stake 
(2010), triangulation uses multiple data sources to facilitate interpretation from different 
perspectives. Also, to ensure accuracy, the researcher compared participants' opinions and 
suggestions with existing research on pharmaceutical shortages.  
The findings showed multiple viewpoints. The themes were derived from the analysis of 
findings from interviews in a qualitative, multiple case study. The major and minor themes that 
emerged for each research question were:  
RQ1: Manufacturing issues are the primary reasons for hospital pharmaceutical 
shortages. The minor themes: alternatives/replacement pharmaceutical, raw material shortage, 
and natural disasters.  
RQ2: Supply and demand management is just as challenging as shortages. The minor 
themes: greater transparency, prepared for shortages, and COVID-19, the global pandemic.  
RQ3: There are pros and cons to using predictive analytics. The minor theme: pros and 
cons and COVID-19.  
A common form of analysis within qualitative research is searching for meaning patterns 
in the data to identify central themes. One discounted analytical strategy in qualitative data 
analysis is how researchers respond to and potentially use exceptional data. Data that tell us 
something about a central theme deviates significantly from its defining plot and characteristics 
(Phoenix & Orr, 2017). For this study, the researcher learned early in the data collection that the 
Coronavirus (COVID-19) would be an exceptional outlier. In examining the rising costs of 
hospital pharmaceutical shortages and the impact on patient care, the researcher did not expect 
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that there would be a global pandemic that would deviate the study from day to day 
pharmaceutical shortages to the shortages caused by COVID-19. The current shortage of vitally 
needed drugs is a dangerous situation that is exacerbated by the COVID-19 pandemic.  
Lack of tests, masks, other personal protective equipment, and ventilators threatens to 
worsen our state. Unfortunately, however, we are already in the midst of another devastating 
problem: the scarcity of medicines essential for COVID-19 management. Medication shortages 
anticipated to worsen with time, directly affect COVID-19 patients, and pose a threat to the 
health and safety of non-COVID-19 patients with other illnesses (Choo & Rajkumar, 2020). 
Like other at-risk services in this crisis, shortages of drugs have been invisible but 
endanger our ability to resolve this pandemic and patients' health with other diseases. Shortages 
include medications known as effective COVID-19 treatments, such as chloroquine and 
hydroxychloroquine. In reality, hydroxychloroquine is now difficult to access because of off-
label prescriptions and hoarding for patients without COVID-19 who need this medication to 
treat rheumatoid arthritis and other autoimmune disorders. The fragility of the complex supply 
chain of medicinal products has not been generated overnight, and yet we must overcome its 
limitations quickly and effectively (Lee, 2020). 
Applications to Professional Practice 
This sub-section analyzed the applicability of findings to the professional practice of 
business. Moreover, this section also addressed the biblical context and the strategic management 
field of study. This research will benefit hospital pharmacies, hospital pharmaceutical supply 
chains, and aide in the planning for the effects of pharmaceutical shortages during a global 
pandemic. Only half of the ten participants in this study felt their hospital is prepared for 
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shortages. However, none of the hospitals represented by the participants had a one-size-fits-all 
plan on how to manage during a pharmaceutical shortage strategically.  
Improved Business Practice  
Hospitals recognized the need to improve their pharmaceutical operations by 
strengthening their overall supply chains by combining processes such as sourcing, inventory 
management, and demand forecasting to plan and meet the expected product demand (AlAzmi & 
AlRashidi, 2019). Although drug shortages are a chronic problem, an increasing number of 
hospitals and healthcare facilities are putting in place teams and strategies to address the 
logistical and ethical challenges of shortages to better anticipate and cope with them. As stated 
by Participant 003, establishing a strategy and procedures will help a hospital respond rapidly 
when there is a shortage and alleviate some of the effects (personal communication, July 5, 
2020).  
Identifying supply chain shortfalls and mitigation strategies. The findings show that 
hospitals identify shortfalls in supply chain management systems and discover areas for 
prevention and cost reduction of future shortages. Hospital pharmaceutical leadership should 
consider creating a strategy to address drug shortages. The strategy should include three stages, 
according to the American Society of Health-System Pharmacists (ASHP) evaluation, planning, 
and contingency (Hoffman et al., 2008). Participant 001 backs this concept by commenting that 
strategy should include a unique process because every single drug requires a unique solution 
and guidance (personal communication, June 30, 2020). More significantly, the right drug 
management approach for the system and organization will strengthen patient safety by 
encouraging more efficient response to urgent needs. In reality, pharmacies are best able to 
reduce shortages entirely by recognizing trends for enterprise drug use and channeling necessary 
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drugs to the right places. Real-time inventory visibility makes it easy to identify the drug's 
quantities and locations when there is a shortage (Mokgatlha & Kadama, 2017). 
Learning from COVID-19 and planning for the future. Participants 002, 007, and 010 
identified several approaches to reduce the effect on patient health and treatment from drug 
shortages in the second wave of COVID-19. According to the same participants, addressing drug 
shortages due to the pandemic cannot be addressed using institutional-level approaches. Instead, 
it requires the intervention of international health and regulatory bodies at national and 
occasionally. The value of preventing drug shortages and finding solutions has become more 
prevalent in the COVID-19 pandemic context. Because of COVID-19, the rapidly increasing 
demand for pharmaceutical products puts added pressure on hospitals and health systems to 
better maintain the inventory of medicines to sustain patient care. There is a shortage of effective 
drugs used to ease breathing issues, relieve discomfort, and sedate patients with coronavirus.  
Hence, hospital pharmacies also need inventory- and shortage-management strategies to 
survive the surge (Sharma et al., 2020). Since much of the world has outperformed COVID-19's 
first wave, pharmacies can be pushed through infrastructure and technology to improve 
inventory management processes that increase visibility and help managers make better choices. 
Where health providers can adjust and monitor expenditure to the entire network's needs, there 
are significant positive effects on the bottom line and on the bottom line (personal 
communication, July 3, 2020). 
Use of Strategic Management. Since the birth of "business planning" and "business 
policy" in the 1960s, the strategic management field has grown considerably. Pioneering 
experiments were essentially conventional, customary, and mostly focused on profound case 
studies. The development of strategic management into a recognized academic research area has 
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resulted from the introduction of commonly used analysis methods in economics (Dagnino & 
Cinci, 2015). The study revealed a need for continued research on communication between 
manufacturers amid a shortage. Every manufacturer has systems in place to track, manage 
orders, and monitor supplier performance. However, manufactures are sometimes not 
forthcoming with their information. The manufacturing sector needs to generate, share, and 
disseminate up-to-date information to survive and compete in today's global economy. The real 
value of information exchange within the supply chain can be determined by the fact that the 
benefits received outweigh the costs involved. Coordination and alignment of supply chain 
management (SCM) have long been the concerns of both the academic and business community 
(Nunes et al., 2006).  
There is a Need for Pharmaceutical Inventory Automation. The study also revealed 
that there is a need for further exploration of the use of inventory automation. According to 
Acosta et al. (2019), it is crucial to create a consensus to construct or adopt definitions of 
shortage and scarcity, and to define all local definitions, to produce a glossary relating to 
inventory automation and the availability of medicines to encourage the collection of data from 
various sources and to manage potential situations better. It is also important to remember that if 
there is a shortage due to logistical and availability constraints, and it is not feasible to deliver 
prescription products on time, alternative paths must be approved and communicated effectively. 
Automating analytics functions allows for fast par-level changes, which, in effect, helps ensure 
that essential drugs are not stored in a hospital (Bogaert et al., 2015). 
Participant 008 stated that the drug inventory level should be monitored, but acquisition 
speed is also relevant. Partnerships with suppliers to optimize process parts may affect 
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how easily alternative products can be inserted into a shorted product (personal 
communication, June 25, 2020).  
Hospitals, regulatory bodies, and academia need to tackle the shared problem of lengthy 
and expensive medical product development programs with high attrition rates and lack of 
automation in the face of these challenges. This involves well-structured translational sciences 
and pre-competitive research and the curriculum's requisite background for which planning and 
building skills are essential. For the success of pharmacology as a discipline, standards, 
automation, knowledge sharing, and applied focus training are important (Woodcock, 2010). 
Often, an automated device may be used to inform inventory management if the drug demand is 
down. Pharmacies should be informed whether there is a newer medication with improved 
clinical results available. Automation can alert the pharmacy to the shift in traditional 
prescription habits, and whether the PAR levels need to be adjusted, which is the number of 
drugs they need to have on-site at any time in safety. To be more effective purchasers, 
pharmacies need time and skill to collect data from their automated systems. As more successful 
consumers, they save money and cut waste (Bogaert et al., 2015). 
Invest in Systems and Human Capital. In addition to the recommendation for 
automation, strengthening an organization’s commitment to providing efficient patient care, an 
investment should be made for both systems and human capital. A few participants in the study 
expressed their frustration with the lack of human capital resources to manage drug shortages. 
Full-time workers are needed to handle medication shortages and felt that the duties associated 
with this phase had been limited to the time usually dedicated to patient care and medication 
protection, risk-taking, and error contributing (personal communication, June 25, 2020). 
Moreover, dedicated human capital can minimize the time between the expiry date of the drug 
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and its withdrawal from inventory and creating a crucial prescription list that enables less 
comprehensive control over inventory changes. 
Biblical Framework  
God has perfect strategic foresight. God is omnipresent omniscient and eternal; thus, He 
knows everything about everybody in the past, present, and future. In this study, the biblical 
insights align with the need for supply to the care of patients. God is aware of the requirements 
for his people and promises to supply what they need. "But my God shall supply all your need 
according to his riches in glory by Christ Jesus" (Philippians 4:19, KJV).  
The Christian worldview of stewardship for an efficient pharmaceutical hospital supply 
chain. We learn from the Bible that the world's ill health, sickness, and death are the product of 
sin. Most of the earthly work of Jesus included battling the curse; He healed people wherever he 
went (see Matthew 15:31). Jesus is the exact image of the being of God (Hebrews 1:3), and by 
curing people, Jesus showed us God's love and His role as the Great Physician by healing people 
who will one day restore all life to health. The principle of stewardship is based on the 
assumption that the earth and its abundant resources belong to God and are made for all our good 
(Psalm 24:1). Pharmaceutical supply chain managers focus on creating resources for the benefit 
of the organization, particularly its patients and shareholders. Stewards calculate both product 
quality and the amount of revenue required to drive results. Stewardship requires accountability. 
As Christians, both what is normal (our person) and what we have gained must be responsible 
for what we have been given. A steward understands that resources are finite and must be 
managed well if all creation is to benefit.  
Stewards must consider the expected effect of supply chains for public health not only on 
drug delivery but also on improving health outcomes and broader development goals, such as 
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improved efficiency and elimination of poverty. Moreover, consider these broader "bottom line" 
principles, the cost-benefit analysis of the alternative supply chain models will be expanded. 
Serving others is an important Old and New Testament concept. Leviticus points out how 
important it is to take responsibility for our neighbor and hired employees (Leviticus 19:13). 
Christian world view at COVID-19 on vigilance. Drug shortages were a fact of life 
before the health crisis. Vigilance on the worlds to prevent the spread of COVID-19 should also 
increase accordingly. It translates directly into saved lives and shows that drug shortages require 
ongoing diligence on clinicians who are up to date to ensure that prescription drugs are safe and 
effective for patients who rely on them. Respect for those who are more vulnerable to illness 
(including the elderly and immune deficiency) will lead us to practice prudence and humility 
while forming the personal power and hope of those who follow Christ (Prov. 24:10). Therefore, 
followers of Christ should model compassion for those who want to respond differently or react 
to situations and events more aggressively (Prov. 18:2). Be compassionate for others. Recognize 
that there is a particular subjectivity in reacting to this crisis, even among those who listen and 
follow God's guidance. 
COVID-19 has taught the world to completely and entirely dependent upon the living 
God. "Jesus Christ, the Son of God, realized he was solely and completely dependent upon his 
Father. Amid the COVID-19 Pandemic, pharmaceutical shortages were high; for the physician, 
patients, and families, the best thing they could do is rely on God's promises. Matthew 11:28-30 
states, "Come to me, all who labor and are heavy laden, and I will give you rest. Take my yoke 
upon you, and learn from me, for I am gentle and lowly in heart, and you will find rest for your 
souls. For my yoke is easy, and my burden is light." In Philippians 4:6, the Bible tells us, "Do not 
be anxious about anything, but in everything by prayer and supplication with thanksgiving let 
108 
 
your requests be made known to God." As the nation thinks about how to act during this tough 
period, Job's words should be remembered. "The Lord gave, and the Lord took away; blessed be 
the Lord's name" (Job 1:21). Just when it appears the world is falling apart, God is still in 
control. 
Recommendations for Action 
The researcher recognized a few recommendations which could apply to hospital 
pharmacies and their supply chains.  
Increase Manufacturer Transparency and Communication 
The first recommendation should be for hospitals to collaborate with the FDA to allow 
manufacturers not only to report when there is a manufacturing issue but to provide more 
information about how long the problem will cause the disruption. Manufacturers must convey 
the advantages and risks of pharmaceutical products to a wide audience in an open way (clear 
and understandable) to inform treatment decisions and clarify the factors and rationales that play 
a part in decisions. Further clarity on a specific prescription shortage will help hospitals prepare 
for shortages further efficiently (Headquarters & Trusts, 2018). If the hospital can appoint 
anyone to focus exclusively on information exchange with the supplier and the FDA, they will be 
able to minimize the shortage by handling the disruption's notification as soon as it occurs. 
Collaboration between academic physicians and industry is essential for advancing scientific 
knowledge and improving patient care. 
Implementation of Inventory Management Automation System 
The second recommendation would be to implement automated inventory tracking. A 
few study participants stated that their hospitals are using manual systems to track 
pharmaceutical supplies. Participant 004 said that having a manual for inventory tracking is not 
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efficient. "To make the right decision for the patients, you need to know what you have got on 
hand at any given time" (personal communication, June 17, 2020). Manual processes take much 
longer, and the margin for error is higher. With drug and distribution errors being a significant 
risk factor for hospitals, implementing an automated dispensing system can reduce the inherent 
human risk factor by creating an auditable trail. While hospitals continue to seek approaches to 
healthcare challenges, advances in technology can bring significant benefits. Hospitals can 
achieve the highest return on these investments by integrating solutions to automation and 
managing workflows, operational improvements, and wise financial decisions (Uy et al., 2015). 
Perform Organization Reviews During and After a Crisis  
The third recommendation is to perform an organizational review during an unexpected 
occurrence. Given the adverse effects on patient care and the possible financial burdens of drug 
shortages, an organization should have a prepared response in the event of a drug shortage 
arising from a global pandemic. Pharmacists and policymakers should work proactively to 
mitigate this threat to patient care and outcomes (Ebrahim et al., 2020). The American Society of 
Health-System Pharmacists has created an assessment method that will help prepare COVID-19 
pandemics in pharmacy departments and encourage pharmacists' involvement in institutional and 
community preparedness. This tool can help find weaknesses in the COVID-19 pandemic 
preparedness of a hospital pharmacy department (ASHP & Coronavirus, 2020). Also, hospital 
pharmacies and supply chains should analyze their activities using a network approach. Frontline 
physicians may help mitigate these medication shortages by recognizing short-term medications, 
evaluating alternatives, and determining risks while using such alternatives (Siow et al., 2020). 
Participant 009 shared that there was no way hospital pharmacies could have been prepared for 
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COVID-19 when it first surged. After a few weeks, hospitals began to assess what would be 
needed in the event of a second wave (personal communication, July 8, 2020). 
Recommendations for Further Study 
This study had some limitations, which leaves room for further research.  
Participants  
The participants in this study were expected to have a bachelor's degree. While they had 
many years of experience, many prospective participants did not qualify for the study because 
they did not have a degree or an associate degree. The sample size should be expanded to 
individuals that had a lower degree or no degree.  
Geographic Location 
This study was also limited geographically to only New York City hospitals and hospitals 
on Long Island New York. The study should be expanded to the whole state of New York and 
the tri-state area. 
Specific Pharmaceuticals 
The study focused on all hospital pharmaceutical shortages. The study should be 
narrowed down to specific pharmaceuticals that encounter shortages, identifying more specific 
recommendations for action. 
Timing of Study 
The study had an unexpected event occur during the timeframe of the study. The world 
has entered a global pandemic, the novel Coronavirus or COVID-19. At the time of field study 
and data collection, the researcher did not think about how much COVID-19 would have an 
impact. This study focused on the rising cost of hospital pharmaceutical shortages and the impact 
on patient care. One of the most significant factors of COVID-19 would be pharmaceutical and 
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equipment shortages. If the study were conducted pre-pandemic, the findings would be different. 
COVID-19 dominated the findings for pharmaceutical shortages related to the pandemic. This 
study should be conducted once the pandemic has lifted, and the supply chain returns to what 
they may consider typical operational supply chain issues.  
Different Analytical Approaches 
This study used a qualitative approach to research designed to capture the perceptions 
and perspectives of the participants. Mixed research approaches would have provided 
experience, expertise, and data on pharmaceutical shortages that could improve the reliability 
and understanding of pharmaceutical shortages in hospitals. 
Internal Factors and Risks of Pharmaceutical Shortages 
The researcher believes that there should be a further examination of the internal factors 
and risks of hospital pharmaceutical shortages related to internal communication. The 
importance of constant communication and good collaboration between hospital leadership, 
hospital pharmacies, health providers, and patients is demonstrated by analyzing a hospital drug 
shortage. The role of communication internally should be explored as it can affect the ability to 
order supplies and to pay for the supplies ordered, stockpiling and pharmaceutical delivery 
disruptions. Additionally, what measures can be taken to mitigate risk when it comes to a 
breakdown with internal communications between the hospital supply chain and providers. 
Standardizing our drug shortages management process and effectively communicating these 
shortages plans throughout the hospital has brought about several meaningful results. 
External Risks in the Supply Chain 
This study also allows further research on external risks in the supply chain and the 
relation to communication. The supply chain's external risks can be caused by supply and 
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demand risks, natural disasters, and business risks. When these risks occur externally in the 
supply chain, there is not always a path forward that is communicated clearly. A breakdown in 
communication needs to be explored with recommendations on how to decrease the impact in the 
supply chain. Unfortunately, there are a number of suppliers who are not as transparent to their 
customers as they should be. This breakdown in supplier contact will bring multiple risk factors 
into your supply chain. Better communication contributes to more efficient business practices. 
Suppliers that interact well will also understand your criticality of the shortage and what is 
needed to minimize the risks. When a supplier has these characteristics, errors related to 
communication problems are much less likely. For the safe management of drug shortages, 
planning, standardization, communication and monitoring are critical. Although planning for any 
potential shortage of medicines may be difficult, diligent planning may minimize the adverse 
effects on both patients and providers. 
Reflections 
This section includes a reflection of the researcher's experience with the research process. 
Reflections concentrate on the effect that personal values, preconceived ideas, and previous 
knowledge may have had on the topic of study. The researcher has fifteen years of healthcare 
administration experience, so effective and efficient patient care is a significant personal value. 
However, the researcher is aware that there are many challenges in different aspects of patient 
care, hence the reason for this study. Any fears of personal bias were diminished as the 
participants were so passionate about sharing their experiences with the business problem. The 
researchers had a change of attitude when COVID-19's surprising influence pushed the study in a 
different direction. There was not a single interview that did not discuss the effect of COVID-19 
on hospital pharmaceutical shortages. COVID-19 dominated the results and changed the data 
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collection process. The researcher planned on conducting in-person interviews, but the 
interviews were conducted virtually or completed in writing because of the restrictions and social 
distancing rules. Scheduling was the most challenging, as the participants were heavily involved 
with COVID-19 patient care efforts.  
The biblical principles relating to the rising cost of hospital pharmaceutical shortages and 
the impact on patient care included faith in God through challenges, Proverbs 3:5 declares, 
"Trust in the LORD with all thine heart, and lean not unto thine own understanding." There will 
always be challenges in business, but God gives us direction on how to respond. It's from the 
Bible, James 1:2-4, NIV. "Consider it with pure joy, my brothers, as you face many kinds of 
trials, for you know that the testing of your faith produces perseverance. Perseverance must 
finish its work so that you may be mature and complete, not lacking in anything." 
Summary and Study Conclusions 
The objective of this case study was to explore the problem of the rising cost of hospital 
pharmaceutical shortages and the impact on patient care. Additionally, the study examined the 
use of predictive analytics as a possible solution. The study applied a qualitative research method 
and a case study design. Three research questions were developed in response to the problem and 
purpose of the study. RQ1. How are hospitals challenged by the rising costs of hospital 
pharmaceutical shortages due to manufacturing problems? RQ2. What role does supply and 
demand management play in hospital pharmaceutical shortages? RQ3. How would predictive 
analytics improve patient care inefficiencies relating to rising costs of hospital pharmaceutical 
shortages?  
The researcher conducted qualitative semi-structured questions based on the interview 
guide in appendix A. The themes that emerged from this qualitative multiple case study include 
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1) manufacturing issues are the main cause of hospital pharmaceutical shortages, 2) supply and 
demand management are just as challenging as shortages, and 3) there are pros and cons to using 
predictive analytics. After the researcher presented the findings and themes that emerged, there 
were recommendations made for action and further study. Finally, biblical principles relating to 
the study were presented. The literature confirmed the findings; however, there is more to be 
learned regarding hospital prescription shortages and, in particular, the effects of shortages 
during a global pandemic.  
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Appendix A: Interview Guide 
Time of Interview:  
Date:  
Place:  
Interviewer: LeTicia L. Currin  
Interviewee:  
Position of interviewee:  
Introduction: Thank you for being willing to contribute to the study to examine the 
rising costs of hospital pharmaceutical shortages and the impact on patient care: exploring the 
use of predictive analytics in New York area hospitals. I appreciate your participation. This 
interview will consist of semi-structured question. Interviews are documented and then 
transcribed. Recordings are kept for three years on a password-locked computer and then 
deleted. Such recordings will only be available to the researcher. 
Are there any questions before we begin? 
Opening Questions: (Icebreaker) 
Engage the interviewee so they will be at ease. Ask them how their day has been before starting 
the questions.  
1. How long have you been here at hospital A and what is your position? 
2. Did you get a degree in pharmacy or any other related field? 
3. Why did you decide on a career in pharmacy? 
4. Do you work directly with hospital pharmaceuticals? 
5. What is your role when there are pharmaceutical shortages? 
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6. Before we begin the content questions, is there anything else about your background you 
would like to share? 
Researcher note: After the opening questions, remember, you are trying to obtain all the 
information you can relating to rising costs of hospital pharmaceutical shortages and the impact 
on patient care in New York area hospitals. Inform the interviewee that the next set of questions 
will be based on this business problem.  
Use Probes: Ask for more information, ask for examples, ask for explanations.  
Content Questions: Based on the research questions and sub-questions. 
1. What is the history of pharmaceutical shortages over the last few years in your 
hospital?  
a. What are the causes of pharmaceutical shortages in your hospital? 
b. Do you know how much the costs of pharmaceutical increased due to the 
shortages? If not, can you direct me to the person that may have the answer? 
c. What are the most significant challenges with pharmaceutical shortages? 
d. How often does your hospital encounter drug shortages? 
e. How are patients affected by pharmaceutical shortages? 
f. How are your hospitals handling any shortages due to the Coronavirus? 
2. What role does the manufacturer play in pharmaceutical shortages? 
a. What type of pharmaceuticals have the highest case of shortages? 
b. Does your hospital have a standard process for drug shortages? If so, what is 
the process? Can I obtain a copy of the process document?  
c. How does supply and demand factor in? Would you say that the hospital 
supply chain is prepared for shortages? 
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d. What specific measures does the hospital take to minimize or avoid the 
shortages of pharmaceuticals? Do you think that there are any more steps that 
could be taken? 
3. Do you think that data is useful when it comes to pharmaceutical shortages? 
4. Does your hospital rely on data when it comes to forecasting pharmaceutical 
shortages?  
a.  If so, what type of forecasting system does the hospital use?  
b. If not, what other methods does your hospital use to track shortages? 
5. Are you familiar with the term predictive analytics? (If not, the researcher will 
explain). 
a. Do you think a predictive analysis forecast will confirm continual care by 
assuring there is an alternative pharmaceutical when a shortage occurs? 
b. What do you think of predictive analytics that classify commonly correlated 
consumer variables with product shortages? 
c. Do you think predictive analytics can identify trends and patterns in hospital 
pharmaceuticals, and develop strategies for repackaging bulk drugs in smaller 
unit doses whenever possible? 
d. Could predictive analytics help in the shortage of pharmaceuticals with the 
Coronavirus? 
Is there anything else you would like to add?  
Closing Statement: Thank you for participating in the study. Please be assured that your 
comments will remain confidential and that you will receive a copy of your interview 
transcript. 
